• 340-plus papers. Index and Listing are below.  The listing does not include papers published prior to 1975 mostly in the area of the biochemical pharmacology of sodium transport and Na-K-ATPase.
  (Click HERE for papers prior to 1975)
• 100-plus abstracts, two books, four volumes of proceedings. Numerous articles published and reprinted in lay journals..
• Drugs and the Performance Horse, by Thomas Tobin. Foreword by HRH, The Duke of Edinburgh. 480 pp., Springfield, Illinois: Charles C. Thomas, 1981.
• Equine Drugs and Vaccines: A Guide for Owners and Trainers, Eleanor Kellon with Thomas Tobin. 336 pp., Breakthrough Press, 1994.
• Proceedings of the Workshop on Testing for Therapeutic Medications, Environmental and Dietary Substances in Racing Horse. 218 pages, 1995.
• Furosemide in the Horse: Its Actions, Effects, and Regulatory Control.  Proceedings of a Testing Integrity Program Workshop and Seminar, 124 pages, Wind Publications, 2000.
• World Rules for Equine Drug Testing and Therapeutic Medication Regulation: 2012 Policy of the National Horsemen's Benevolent and Protective Association. Thomas Tobin, Kimberly Brewer, and Kent H. Stirling.  Wind Publications, 2012.
  

Click on the book for further information:

Publications Subject Index & Publications List

1975 to 2003

Publications  (1975 to date)

PUBLICATIONS:

1. Post RL, Kume S, Tobin T, Orcutt B, Sen AK:  Flexibility of an active centre in (Na++K+)-dependent ATPase.  J Gen Physiol 54(1)Part 2:306-326, 1969.

2. Sen AK, Tobin T, Post RL:  A cycle for ouabain inhibition of the (Na++K+)-ATPase.  J Biol Chem 244:6596-6604, 1969.

3. Tobin T, Banerjee SP, Sen AK:  Allosteric interactions in the (Na++K+)-ATPase.  Nature 225:745, 1970.

4. Tobin T, Sen AK:  Stability and ligand sensitivity of  [3H]-ouabain binding to the (Na++K+)-ATPase.  Biochem Biophys Acta 198:120-131, 1970.

5. Akera T, Hook JB, Tobin T, Brody TM:  Cardiac glycoside sensitivity of (Na++K+)-activated ATPase in newborn rats.  Res Commun Chem Pathol Pharmacol 4:599-706, 1972.

6. Tobin, T, Baskin SI, Akera T, Brody TM:  Nucleotide specificity of the (Na++K+)-dependent adenosine triphosphatase.  Molec Pharmacol 8:256-263, 1972.

7. Tobin T, Brody TM:  Rates of dissociation of enzyme-oubain complexes and K0.5 values in (Na++K+)-adenosine triphosphatase from different species.  Biochem Pharmacol 21:1553-1560, 1972.

8. Tobin T, Henderson R, Sen AK:  Species and tissue differences in the rate of dissociation of ouabain from the (Na++K+)-ATPase.  Biochem Biophys Acta 274:551-555, 1972.

9. Akera T, Baskin SI, Tobin T, Brody TM:  Ouabain: Temporal relationship between the ionotropic effect and the in vitro binding to and dissociation from (Na++K+)-activated ATPase.  Naunyn-Schmiedeberg's Archiv fur Pharmacol 277:151-162, 1973.

10. Akera T, Rech RH, Marquis WJ, Tobin T, Brody TM:  Lack of relationship between brain (Na++K+)-activated adenosine triphosphatase and the development of tolerance to ethanol in rats.  J Pharmacol Exp Ther 185:594-601, 1973.

11. Tobin T, Akera T, Baskin SI, Brody TM:  Calcium and sodium and potassium dependent adenosine triphosphatase: Its mechanism of inhibition and identification of the EI-P intermediate.  Mol Pharmacol 9:336-349, 1973.

12. Tobin T, Akera T, Hogg RE, Brody TM:  Ouabain binding to sodium- and potassium-dependent triphosphatase: Inhibition by the b-y-methylene analogue of adenosine triphosphatase.  Mol Pharmacol 9:278-281, 1973.

13. Tobin T, Akera T, Ku D, LU MC: Reversibility of the interaction of strophanthidin bromacetate with the cardiotonic steroid binding site of sodium- and potassium-dependent adenosine triphosphatase.  Mol Pharmacol 9:676-685, 1973.

14. Tobin T, Dirdjosudiono S, Baskin SI:  Pharmacokinetics and distribution of diphenylhydantoin in kittens.  Am J Vet Res 34:951-954, 1973.

15. Akera T, Baskin SI, Tobin T, Brody TM:  Cardiac glycosides: Temporal relationship between the inotropic action and binding to and dissociation from Na++K+-activated ATPase in vitro. Recent Advances in Studies on Cardiac Structure and Metabolism, Vol 4, Myocardial Biology (ed NS Dhalla), University Park Press, Baltimore , pp 139-147, 1974.

16. Akera T, Baskin SI, Tobin T, Brody TM, Manian AA: 7-8-Dihydroxychlorpromazine:  (Na++K+)-ATPase inhibition and positive inotropic effect.  Advances in Biochem Psychopharmacol 9:633-640, 1974.

17. Akera T, Brody TM, So RH-M, Tobin T, Baskin SI:  Factors and agents that influence cardiac glycoside Na++K+-ATPase interaction.  Ann NY Acad Sci 242:617-634, 1974.

18. Akera T, Tobin T, Gatti A, Shieh I-S, Brody TM: Effect of potassium on the conformational state of the complex of ouabain with sodium- and potassium-dependent adenosine triphosphatase.  Mol Pharmacol 10:509-518, 1974.

19. Ku D, Akera T, Tobin T, Brody TM:  Effects of rubidium on cardiac tissue, Inhibition of Na ++K+-ATPase and stimulation of contractile force.  Res Commun Chem Pathol Pharmacol 9: 431-440, 1974.

20. Tobin T, Akera T, Baskin SI, Brody TM:  The mechanism of the Ca++ ion inhibition of sodium-potassium ATPase.  Recent Advances in Studies on Cardiac Structure and Metabolism.  Vol. 4, Myocardial Biology (ed NS Dhalla), University Park Press, Baltimore , pp 139-147, 1974.

21. Tobin T, Akera T, Brody TM:  Studies on the two phosphoenzyme conformations of Na++K+-ATPase.  Ann NY Acad Sci 242: 120-132, 1974.

22. Tobin T, Akera T, Dworin JZ, Brody TM:  Fluoride nephropathy: Lack of direct involvement of renal ATPase.  Canad J Physiol Pharmacol 52:489-495, 1974.

23. Tobin T, Akera T, Han CS, Brody TM:  Lithium and rubidium interactions with sodium- and potassium-dependent adenosine triphosphatase: A molecular basis for the pharmacological actions of these ions.  Mol Pharmacol 10:501-508, 1974.

24. Tobin T, Akera T, Lee CY, Brody TM:  Ouabain binding to (Na++K+)ATPase: Effects of nucleotide analogues and ethacrynic acid.  Biochem Biophys Acta 354:102-117, 1974.

25. Tobin T, Tai Cy, Arnett S:  Recovery of procaine from biological fluids.  Res Commun Chem Path Pharmacol, 11(2):187-194, 1975.

26. Abramson HN, Huang CL, Wu TF, Tobin T:  Thiocardenolides. I.  Synthesis and biological actions of 3- -thiocyanato-14 -hydroxy-5- -card-20(22)-endide.  J Pharm Sci 65:765-768, 1975.

27. Ku D, Akera T, Tobin T, Brody TM:  Effects of monovalent cations of cardiac Na++K+-ATPase activity and on contractile form.  Naunyn-Schmiedeberg's Archiv fur Pharmacol 20: 113-131, 1975.

28. Tobin T, Abramson H:  Irreversible inhibition of [3H]-ouabain binding to Na++K+-ATPase by digoxigenin-3-12 di-bromacetate, an alkylating derivative of digoxigenin.  Eur J Pharmacol 32: 243-250, 1975.

29. Tobin T, Akera T:  Shodowmycin, a nucleotide site directed inhibitor of Na++K+-ATPase.  Biochem Biophys Acta 389: 126-136, 1975.

30. Tobin T, Akera T, Brody SI, Brody TM:  The mechanism of interaction of cassaine with Na++K+-ATPase.  Biochemical Soc Transactions 2:1375-1378, 1975.

31. Tobin T, Akera T, Brody TM:  Gel electrophoretic identity of the Na+, Mg++, and Na+Ca++-stimulated phosphorylations of Na+K+-ATPase.  Biochem Biophys Acta 393, 117-125, 1975.

32. Tobin T, Akera T, Brody TM, Tanaja HA:  Irreversible inhibition of Na++K+-ATPase: Strophanthidin 3,5-bisparabenzoylbenzoate, a photo-chemical analog of strophanthidin.  Res Commun Chem Pathol Pharmacol 10: 605-617, 1975.

33. Akera T, Ku D, Tobin T, Brody TM:  The complexes of ouabain with sodium- and potassium-activated adenosine triphosphatase formed with various ligands: The relationship to the complex formed in the beating heart.  Mol Pharmacol 12:101-114, 1976.

34. Tobin T, Blake JW, Tai Cy, Arnett S:  The pharmacology of procaine in the horse. I. A preliminary report.  Am J Vet Res, 37:1107-1110, 1976.

35. Blake JW, Tobin T:  The gas-liquid chromatograph and the electron capture detector in equine drug testing.  Brit J Sports Med, 10:129-132, 1976.

36. Han CS, Tobin T, Akera T and Brody TM:  Effects of alkali metal  cations on phospho-enzyme levels and  [3H]-ouabain binding to Na++K+-ATPase.  Biochem Biophys Acta 429:993-1005, 1976.

37. Ku D, Akera T, Tobin T, Brody TM:  Comparative species studies on the effects of monovalent cations and ouabain on cardiac Na++K+-ATPase and contractile force.  J Pharm Exp Therap 197(2):458-469, 1976.

38. Miller JR, Blake JW, Tobin T:  Electron capture detection of an apomorphine-heptafluorobutyrate derivative at low picogram levels.  Res Commun Chem Path Pharmacol, 15(3):447-455, 1976.

39. Roberts BL, Blake JW, Tobin T:  Drug interactions in the horse: Effect of furosemide on plasma and urinary levels of phenylbutazone.  Res Commun Chem Path Pharmacol, 15:257-265, 1976.

40. Tobin T:  Drugs, Horses and the Kentucky Equine Drug Research Program.  Proc 2nd Conv Natn'l Assoc. State Racing Commissioners, San Diego, CA, 1976, pp 89-99.

41. Tobin T:  Drugs, Racehorses and the Kentucky Drug Research Program. The Blood-Horse, Vol CII(14):1453-1455, April 1976.

42. Tobin T, Akera T, Brody SI, Ku D, Brody TM:  Cassaine: Mechanism of inhibition of Na++K+-ATPase and relationships of this inhibition to cardiotonic actions.  Eur J Pharmacol 32: 133-145, 1976.

43. Tobin T, Akera T, Han CS, Brody TM:  Studies on the stable inhibition of Na++K+-ATPase by cassaine.  Eur J Pharmacol 35: 59-68, 1976.

44. Tobin T, Akera T, Taneja HA, Brody TM:  Cardiotonic site directed irreversible inhibition of Na++K+-ATPase by 3-azidoacetyl-strophanthidin, a photochemical analogue of strophanthidin.  Eur J Pharmacol 35:68-76, 1976.

45. Tobin T, Blake JW: A review of the pharmacology, pharmacokinetics and behavioral effects of procaine in the Thoroughbred Horse.  Brit J Sports Med, 10:109-116, 1976.

46. Tobin T, Swerczek TW, Blake JW:  Pine-oil toxicity in the horse: Drug detection, residues and pathological changes.  Res Commun Chem Path Pharmacol 15:291-301, 1976.

47. Tobin T, Blake JW, Tai Cy, Sturma L, Arnett S:  The pharmacology of procaine in the horse II. The procaine esterase properties of equine plasma and synovial fluid.  Am J Vet Res, 37:1165-1170, 1976.

48. Tobin T, Tai Cy, O'Leary J, Sturma L, Arnett S:  The pharmacology of procaine in the horse. III. Evidence against the existence of a procaine-penicillin complex.  Am J Vet Res, 38:437-442, 1977.

49. Gabel AA, Tobin T, Ray RS, Maylin GA :  Furosemide (Lasix®) in horses: A review.  J Eq Med Surg, 1:215-218, 1977.

50. Gabel AA, Tobin T, Ray RS, Maylin GA :  Phenylbutazone (ButazolidinR) in horses: A review.  J Eq Med Surg, 1:221-225, 1977.

51. Miller MR, Roberts BL, Blake JW, Valentine RW, Tobin T:  Drug interactions in the horse. III. Effects of furosemide on urinary concentrations of glucuronide metabolites of pentazocine.  Res Commun Chem Path Pharmacol, 17;447-456, 1977.

52. Tobin T:  Furosemide (Lasix®) in the horse: An overview.  Proc 23rd Annual Conv AAEP, Vancouver , 1977, pp 419-421.

53. Tobin T, Akera T:  Interaction of ouabain and cassaine with Na++K+-ATPase and its relationship to their inotropic actions.  In: Drug Action at the Molecular Level, MacMillan Pub Co, London , 1977, pp 213-133.

54. Tobin T, Blake JW:  The pharmacology of procaine in the horse V. Relationships between plasma and urinary concentrations of procaine.  J Eq Med Surg, 1:188-194, 1977.

55. Tobin T, Blake JW, Maylin G:  Use of bumetanide in horses.  Am J Vet Res, 38:413, 1977.

56. Tobin T, Blake JW, Sturma L, Arnett S, Truelove J:  The pharmacology of procaine in the horse: Pharmacokinetics and behavioral effects.  Am J Vet Res, 38:637-647, 1977.

57. Tobin T, Blake JW, Valentine R:  Drug interactions in the horse. I. Effects of chloramphenicol, quinidine and oxyphenbutazone on phenylbutazone metabolism.  Am J Vet Res, 38:123-127, 1977.

58. Ballard S. White CB, Woods WE, Voos J, Tobin T:  Biochemical and behavioral effects of reserpine in the horse.  Presented at the 2nd Equine Pharmacology Symposium, Ohio State University , Columbus , OH , 1978.

59. Blake JW, Tobin T, Roberts BL:  A modified Folin-Denis over-spray for the detection of phenolic alkaloidal drugs.  Irish Vet J, pp 209-213, December 1978.

60. Combie J, Dougherty J, Shults T, Tobin T:  Quantitation and selective blockade of response to narcotic analgesics in the horse.  2nd Equine Pharmacology Symposium, The Ohio State University , Columbus pp 183-188, 1978.

61. Roberts BL, Blake JW, Tobin T:  The pharmacology of furosemide in the horse. II. Its detection, pharmacokinetics and clearance from urine.  J Eq Med Surg, 2:185-194, 1978.

62. Shults T, Roberts BL, Blake JW, Tobin T:  The detection, identification and basic pharmacology of furosemide in the horse.  2nd Equine Pharmacology Symposium, the Ohio State University , Columbus , pp 43-57, 1978.

63. Tobin T:  A review of the pharmacology of furosemide in the horse.  Proc 3rd Int’l Equine Doping Conference, Rome , March 1977.  Atti Della Conferenza Int’l Sul Doping, pp 323-352, 1978.

64. Tobin T: A review of the pharmacology of procaine in the horse.  J Eq Med Surg, 2:209, 213-214, 1978.

65. Tobin T:  A review of the pharmacology of reserpine in the horse.  J Eq Med Surg, 2(10):433-438, 1978.

66. Tobin T: Chemotherapy in the horse: The penicillins.  J Eq Med Surg, 2(11):475-479, 1978.

67. Tobin T: Narcotic analgesics and the opiate receptor in the horse.  J Eq Med Surg, 2:397-399, 1978.

68. Tobin T:  Pharmacology Review: A review of recent research on furosemide in the horse.  J Eq Med Surg, 2:314, 320-321, 1978.

69. Tobin T: Pharmacology Review: Testing for drugs in horses.  J Eq Med Surg, 2(12):518-524, 1978.

70. Tobin T: Plasma and urinary drug concentrations, drug "clearance times", and pharmacological effects.  J Eq Med Surg, 2(6):262-267, 1978.

71. Tobin T: The anabolic steroid androgen group of drugs.  J Eq Med Surg, 2:163-165, 1978.

72. Tobin T, Roberts BL, Miller RW:  The pharmacology of furosemide in the horse. I. Effects on the disposition of procaine, methylphenidate, phenylbutazone and pentazocine.  J Eq Med Surg, 1:402-409, 1978.

73. Tobin T, Roberts BL, Swerczek TW, Crisman M:  The pharmacology of furosemide in the horse. III, Dose and time response relationships, effects of repeated dosing, and performance effects.  J Eq Med Surg, 2:216-226, 1978.

74. Akera T, Gubitz RH, Brody TM, Tobin T:  Effects of monovalent cations on Na++K+-ATPase in rat brain slices.  Europ J Pharmacol, 55:281-292, 1979.

75. Combie J, Dougherty J, Nugent E, Tobin T:  The pharmacology of narcotic analgesics in the   horse. IV. Dose and time response relationships for behavioral responses to morphine, meperidine, pentazocine, anileridine, methadone, and hydromorphone.  J Eq Med Surg, 3:377-385, 1979.

76. Combie J, Shults T, Tobin T:  The pharmacokinetics and behavioral effects of fentanyl and other narcotic analgesics in the horse.  Proc 3rd Int’l Symposium on Equine Medication Control, Lexington , June 1979, pp 311-321.

77. Maylin, Fregin, Tobin et al.:  Drugs and performance testing in racing horses.  Report of NASRC Veterinary Chemists Advisory Committee, March 27, 1979 .  NASRC Proceedings, San Francisco, 85-106, 1979.

78. Shults T, Combie J, Dougherty J, Tobin T:  Variable interval conditioning in the horse: A sensitive measure of behavior.  Proc 3rd Int’l Symposium on Equine Medication Control, Lexington , June 1979, pp 367-379.

79. Tobin T:  Pharmacology Review: Streptomycin, gentamicin, and the amino-glycoside antibiotics.  J Eq Med Surg, 2:206-212, 1979.

80. Tobin T:  Pharmacology Review: The corticosteroids.  J Eq Med Surg, 3:10-15, 1979.

81. Tobin T: Pharmacology Review: The non-steroidal anti-inflammatory drugs. I. Phenylbutazone. J Eq Med Surg, 3:253-258, 1979.

82. Tobin T:  Pharmacology Review: The non-steroidal anti-inflammatory drugs. II. Equiproxin, meclofenamic acid, flunixin and others.  J Eq Med Surg, 3(7):298-392, 1979.

83. Tobin T, Ballard S:  Pharmacology Review: The phenothiazine "tranquilizers."  J Eq Med Surg, 3:460-466, 1979.

84. Tobin T, Blake JW, Woods WE (eds):  Proceedings of the 3rd Int’l Symposium on Equine Medication Control, Lexington , KY 1979.

85. Tobin T, Combie J, Miller JR, Crisman MW, Blake JW:  The pharmacology of narcotic analgesics in the horse. II. Studies on the detection, pharmacokinetics, urinary clearance times and behavioral effects of pentazocine and fentanyl in the horse.  Irish Vet J, 33:169-176, 1979.

86. Tobin T, Combie J, Shults T:  Pharmacology Review: Actions of central stimulant drugs in the horse. II. J Eq Med Surg, 3(3):102-109, 1979.

87. Tobin T, Combie J, Shults T, Dougherty J:  The pharmacology of narcotic analgesics in the horse. III. Characteristics of the locomotor effects of fentanyl and apomorphine.  J Eq Med Surg, 3(6):284-288, 1979.

88. Tobin T, Maylin GA , Henion J, Woodward C, Ray RS, Johnston J, Blake JW:  An evaluation of pre- and post-race testing and blood and urine drug testing in horses.  J Eq Med Surg, 3(2):85-90, 1979.

89. Tobin T, Miller JR:  The pharmacology of narcotic analgesics in the horse. I. The detection, pharmacokinetics and urinary "clearance times" of pentazocine.  J Eq Med Surg, 3(4):191-198, 1979.

90. Tobin T, White CB, Woods WE:  The pharmacology of reserpine in the horse. II. Effects of reserpine on platelet serotonin uptake and behavior.  J Eq Med Surg, 3:446-451, 1979.

91. Tobin T, Woods WE:  Pharmacology review: Actions of central stimulant drugs in the horse. I. J Eq Med Surg, 3(2):60-66, 1979.

92. Tobin T, Woods WE:  Pharmacology Review: Drug metabolism and elimination in the horse.  J Eq Med Surg, 3(3):150-156, 1979.

93. White CB, Woods WE, Tobin T: The pharmacology of reserpine in the horse. I. Effects of reserpine and imipramine on platelet uptake of serotonin, in vitro and in vivo.  J Eq Med Surg 3(7):325-330, 1979.

94. Tobin T:  An overview of the major antibiotics in equine medicine.  Proc 26th Annual Conf AAEP, Anaheim , CA , December 1980, pp 491-502.

95. Tobin T, Combie J:  The pharmacology and therapeutics of exercise-induced pulmonary hemorrhage (EIPH).  Proc 26th Annual Conf AAEP, Anaheim , CA , December 1980, pp 435-440.

96. Tobin T, Combie JD, Akera T:  Current status of drug receptor theory with specific reference to Na++K+-ATPase and opiate receptors.  Proc 2nd Symposium on Veterinary Pharmacology and Therapeutics, Philadelphia , June 1980, pp 123-165.

97. Tobin T, Nugent T:  Pharmacology of corticosteroid therapy in the horse.  Proc 26th Annual Conf AAEP, Anaheim , CA , December 1980, pp 411-415.

98. Ballard S, Tobin T:  Atypical conditions for qualitative recovery of acepromazine and chlorpromazine from plasma.  J Toxic & Environmntl Hlth, 7:745-751, 1981.

99. Ballard S, Tobin T:  Pharmacology, pharmacokinetics, and behavioral effects of acepromazine in the horse.  Proc 4th Int’l Conf Control Drugs in Racehorses, Melbourne , Australia , May 1981, pp 81-86.

100. Ballard S, Tobin T:  Recovery of acepromazine from equine plasma and its pharmacology in the horse.  Proc 4th Int’l Symposium on Equine Medication Control, 1981.

101. Combie J, Blake JW, Ramey BE, Tobin T:  The pharmacology of narcotic analgesics in the horse: Quantitative detection of morphine in equine blood and urine and logit-log transformations of this data.  Am J Vet Res 42(9):1523-1530, 1981.

102. Combie J, Blake JW, Tobin T:  Phenylbutazone and other drugs in horses racing under a controlled medication program.  Proc 4th Int’l Symposium on Equine Medication Control, Melbourne , Australia , May 1981, pp 68-73.

103. Combie J, Nugent T, Tobin T:  Inability of goldenseal to interfere with the detection of morphine in urine.  J Equine Vet Sci, 2(1):16-19, 1981.

104. Combie J, Nugent T, Tobin T:  The pharmacology of furosemide in the horse. IV. The duration of reduction of urinary concentration of drugs.  J Equine Vet Sci, 1:203-207, 1981.

105. Combie J, Shults T, Nugent E, Dougherty J, Tobin T:  Pharmacology of narcotic analgesics in the horse.  Selective blockade of narcotic-induces locomotor activity.  Am J Vet Res 42:716-721, 1981.

106. Shults T, Kownacki AP, Woods WE, Valentine RW, Dougherty J, Tobin T:  Pharmacokinetics and behavioral effects of methylphenidate in Thoroughbred horses.  Am J Vet Res, 42: 722-726, 1981.

107. Tobin T:  Drugs and the Performance Horse.  Charles C. Thomas, Springfield , IL , 1981.

108. Ballard S, Shults, T, Kownacki AA, Blake JW, Tobin T:  The pharmacokinetics, pharmacological responses, and behavioral effects of acepromazine in the horse.  J Vet Pharmacol Therap, 5:21-31, 1982.

109. Chay S, Woods WE, Nugent TE, Blake JW, Tobin T:  The pharmacology of non-steroidal anti-inflammatory drugs in the horse.  III. Flunixin meglumine (Banamine®).  Equine Practice, 4(10):16-23, 1982.

110. Combie J, Blake JW, Nugent T, Tobin T:  Furosemide, Patella vulgata  b-glucuronidase and drug analysis: Conditions for enhancement of the TLC detection of apomorphine, butorphanol, hydromorphone, nalbuphine, oxymorphone and pentazocine in equine urine.  Res Comm in Chem Pathol Pharmacol 35(1):27-41, 1982.

111. Combie J, Blake JW, Nugent T, Tobin T:  Morphine-glucuronide hydrolysis: Superiority of glucuronidase from Patella vulgata.  Clin Chem, 28(1):83-86, 1982.

112. Nugent TE, Combie J, Weld JM, Burns P, Tobin T:  Effects of enkephalins versus opiates on locomotor activity of the horse.  Res Commun Chem Path Pharmacol, 35(3):405-419, 1982.

113. Shults T, Combie J, Dougherty J, Tobin T:  Variable-interval responding in the horse: A sensitive method of quantitating effects of centrally acting drugs.  Am J Vet Res, 43(7):1143-1146, 1982.

114. Tobin T:  Medication of performance horses.  In: Equine Medicine and Surgery, Am Vet Pub, Inc, Santa Barbara , CA , 1982, pp 158-172.

115. Tobin T, Combie J:  Performance testing in the horse: A review of the role of simple behavioral models in the design of performance experiments.  J Vet Pharmacol Therap, 5:105-118, 1982.

116. Tobin T, Combie J, Nugent T:  Drug "clearance times" and "detection times" in horses: A reappraisal.  J Vet Pharmacol Therap, 5:195-197, 1982.

117. Tobin T, Kamerling S, Nugent TE:  Drugs and equine performance: A review.  In Snow DH, Persson SGB, Rose RJ (eds): Equine Exercise Physiology, Proc 1st Int’l Conf, Oxford , UK , 1982, pp 510-520.

118. Chay S, Woods WE, Rowse K, Nugent T, Blake JW, Tobin T:  The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration.  J Drug Metab Disp, 11(3):226-231, 1983.

119. Chay S, Woods WE, Tobin T:  The pharmacokinetics and blood levels of furosemide after intravenous administration.  Proc 5th Int’l Conf, Cont use of drugs in race horses, Toronto , Canada , June 1983, pp 41-49.

120. Collett L, Kamerling S, Woods WE, Weckman T, Nugent T, DeQuick D, Tobin T:  Clearance times and behavioral effects of clenbuterol in the horse.  Proc 5th Int’l Conf, Cont use of drugs in race horses, Toronto , Canada , June 1983, pp 265-271.

121. Combie J, Nugent T, Tobin T:  Pharmacokinetics and protein binding of morphine in horses.  Am J Vet Res, 44(5):870-874, 1983.

122. DeQuick D, Chay S, Kamerling S, Tobin T:  Pain perception in the horse and its control by medication: An overview.  Proc 5th Int’l Conf, Cont use of drugs in race horses, Toronto, Canada, June 1983, pp 50-51.

123. Greene EW, Woods WE, Tobin T:  Pharmacology, pharmacokinetics, and behavioral effects of caffeine in horse.  Am J Vet Res, 44(1):57-63, 1983.

124. Houston T, Tobin T, Blake JW:  Effect of urine pH on urine levels of oxyphenbutazone in racing horses.  J Drug Metab Dist, 11(6):617-619, 1983.

125. Houston T, Tobin T, Blake JW:  Effect of urine pH on urine levels of phenylbutazone, oxyphenbutazone and g-hydroxyphenylbutazone in racing horses.  Proc 5th Int’l Conf, Cont use of drugs in race horses, Toronto, Canada, June 1983, pp 26-33.

126. Kamerling S, DeQuick D, Crisman M, Weckman T, Nugent T, Tobin T:  Phenylbutazone: Lack of effect on normal cutaneous pain perception in the horse.  Proc 5th Int’l Conf, Cont use of drugs in race horses, Toronto, Canada, June 1983, pp 85-89.

127. Kamerling S, Tobin T:  Pain: Neurophysiology and experimental equine models.  Proc 5th Int’l Conf, Cont use of drugs in race horses, Toronto, Canada, June 1983, pp 52-55.

128. Oehme FW, Tobin T (eds):  Toxicology.  Chapter 13 in Robinson NE (ed), Current Therapy in Equine Medicine.  Sanders, Philadelphia, 1983, pp 573-615.

129. Tobin T:  Phenylbutazone: Its actions, effects, and role in equine medicine.  Modern Equine Practice, Jan/Feb 1983, p 25.

130. Tobin T:  Pre-race testing and its role in equine medication control.  Equine Vet J, 15(1):54-55, 1983.

131. Tobin T:  Testimony on phenylbutazone and furosemide testing before the house subcommittee on criminal justice.  The Horsemen's Journal, 34(7):142-149, 1983.

132. Chay S, Woods WE, Nugent T, Weckman T, Houston T, Sprinkle F, Blake JW, Tobin T, Soma L, Yocum J, Smith JD:  Population distributions of phenylbutazone and oxyphenbutazone after oral and IV dosing in horses.  J Vet Phar Therap, 7:265-276, 1984.

133. Houston T, Chay S, Woods WE, Blake JW, Tobin T:  Phenylbutazone levels in post-race samples from horses racing in Kentucky: A review.  Proc 4th Symposium on Veterinary Pharmacology and Therapeutics, College Station TX, April 1984, pp 96-115.

134. Tobin T, Combie J:  Some reflections on positive results from medication control tests in the USA.  Eq Vet J, 16:43-46, 1984.

135. Weld JM, Kamerling S, Combie J, Nugent TE, Woods WE, Oeltgen P, Tobin T:  The effects of naloxone on endotoxic and hemorrhagic shock in horses.  Res Commun Chem Path Pharmacol, 44(2):227-238, 1984.

136. Blake JW, Tobin T, Chang S-L:  TLC detection of etorphine in equine urines.  Crone DL (ed) Proc 6th Int’l Conf Racing Analysts and Vets, Hong Kong, 1985, pp 205-208.

137. Houston T, Chay S, Woods WE, Combs G, Kamerling S, Blake JW, Edmunson AG, Vessiney R, Tobin T:  Phenylbutazone and its metabolites in plasma and urine of Thoroughbred horses racing in California and Kentucky: Population distributions and the effects of urinary pH.  J Vet Pharm Therap, 8:136-149,1985.

138. Kamerling SG, DeQuick DJ, Weckman TJ, Sprinkle FP, Tobin T:  Differential effects of phenylbutazone and local anesthetics on nociception in the equine.  Eur J Pharm, 107:35-41, 1985.

139. Kamerling S, DeQuick DJ, Weckman TJ, Tobin T:  Dose-related effects of fentanyl on autonomic and behavioral responses in performance horses.  Gen Pharmacol, 16(3):253-258, 1985.

140. Kamerling S, Weckman TJ, DeQuick D, Tobin T:  A method for studying cutaneous pain perception and analgesia in horses.  J Pharm Meth, 13(3):267-274, 1985.

141. Kamerling SG, Weckman TJ, Donahoe J, Tobin T:  The effects of kappa-opioid receptor narcotics in the horse: A new class of equine analgesics.  Crone DL (ed) Proc 6th Int’l Conf Racing Analysts Vets. Hong Kong, 1985, pp 37-45.

142. Karns PA, Kamerling SG, Bagwell CA, Tobin T:  Quantification of equine hoof lameness using an electronic hoof tester.  Crone DL (ed) Proc 6th Int’l Conf Racing Analysts Vets. Hong Kong, 1985, pp 325-329.

143. Soma LR, Sams R, Duer W, Tobin T, Woodward C, McDonald J: Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after various dosage regimens.  Am J Vet Res, 46(4):932-938, 1985.

144. Tobin T, Kamerling SG, Anderson RL:  Drugs and race-horse performance.  Trends in Pharm Sci, 6(3):129-132, 1985.

145. Tobin T, Woods WE, Anderson RC, Houston T, Blake JW:  Influence of urinary pH on concentrations of phenylbutazone and its metabolites in post-race urine samples.  Crone DL (Ed) Proc 6th Int’l Conf Racing Analysts and Vets. Hong Kong, 1985, pp 59-68.

146. Tobin T, Woods WE, Blake JW:  Efficacy and cost of testing for illegal medications in horses.  Crone DL (Ed) Proc 6th Int’l Conf Racing Analysts and Vets. Hong Kong, 1985, pp 113-121.

147. Tobin T, Woods WE, Weckman TJ, Wood TW, Chang S-L, Blake JW: Radioimmunoassay screening for etorphine in racing horses.  Crone DL (ed) Proc 6th Int’l Conf Racing Analysts Vets., Hong Kong, 1985, pp 199-203.

148. Woods WE, Blake JW, Tobin T:  Effects of phenylbutazone and oxyphenbutazone on basic drug detection in high performance thin layer chromatographic systems.  Crone DL (ed) Proc 6th Int’l Conf Racing Analysts and Vets. Hong Kong, 1985, pp 83-88.

149. Woods WE, Chay S, Houston T, Blake JW, Tobin T:  Effects of phenylbutazone and oxyphenbutazone on basic drug detection in high performance thin layer chromatographic systems.  J Vet Pharm Therap, 8:181-189, 1985.

150. Woods WE, Chay S, Houston T, Blake JW, Tobin T:  Efficacy of testing for illegal medication in horses: A survey.  JAVMA, 187:927-930, 1985.

151. Woods WE, Weckman TJ, Blake JW, Tobin T:  Effects of phenylbutazone and oxyphenbutazone on acidic drug detection in high performance thin layer chromatographic systems.  Crone DL (ed) Proc 6th Int’l Conf Racing Analysts and Vets. Hong Kong, 1985, pp 69-82.

152. Blake JW and Tobin T: Testing for drugs in horses. J Eq Vet Sci, 6(2):93-97, 1986.

153. Kamerling SG, DeQuick DJ, Weckman TJ, Tobin T:  Dose-related effects of ethylketazocine on nociception, behavior, and autonomic responses in the horse.  J Pharm Pharmacol, 38(1):40-45, 1986.

154. Tobin T:  Experiences as an expert witness: Educating people while under oath.  J Eq Vet Sci, 6(3):129-133, 1986.

155. Tobin T:  Medication Control: Rules.  J Eq Vet Sci 6(4):191-195, 1986.

156. Tobin T:  Medication Control: The efficacy and cost of drug testing.  J Eq Vet Sci 6(6):333-336, 1986.

157. Tobin T:  Medication Control: Uncertainty in the "Detection Times" for drugs in horses.  J Eq Vet Sci 6(3):124-128, 1986.

158. Tobin T, Blake JW:  Pre-purchase testing for drugs in horses: A review.  J Eq Vet Sci, 6(1):35-39, 1986.

159. Tobin T, Chay S, Kamerling S, Woods WE, Weckman TJ, Blake JW, Lees P:  Phenylbutazone in the horse: A review.  J Vet Pharmacol Therap, 9:1-25, 1986.

160. Tobin T, Woods WE, Tai H-H, Tai C, Weckman TJ, Wood TW, Blake JW:  Radioimmunoassay screening for fentanyl in equine and human urine samples with an iodinated fentanyl analog.  Proc 40th Meeting Assoc of Racing Chem, Lexington, KY, 141-150, 1986.

161. Woods WE, Chay S, Blake JW, Tobin T:  Effects of phenylbutazone on acidic drug detection on high performance thin layer chromatographic systems.  J Pharmacol Meth, 16(4):297-313, 1986.

162. Woods WE, Tai HH, Tai C, Weckman TJ, Wood TW, Barrios H, Blake JW, Tobin T:  High-sensitivity radioimmunoassay screening method for fentanyl.  Am J Vet Res 47(10):2180-2183, 1986.

163. Woods WE, Weckman TJ, Wood TW, Chang S-L, Blake JW, Tobin T: Radioimmunoassay screening for etorphine in racing horses.  Res Commun Chem Path Pharmacol, 52(2):237-249, 1986.

164. McDonald J, Gall R, Wiedenback P, Bass VD, DeLeon B, Brockus C, Stobert D, Wie S, Prange CA, Yang JM, Tai CL, Weckman TJ, Woods WE, Tai H-H, Blake JW, Tobin T:  Immunoassay detection of drugs in horses. I. Particle concentration fluoroimmunoassay detection of fentanyl and its congeners.  Res Commun Chem Path Pharmacol, 57(3):389-407, 1987.

165. Weckman TJ, Tai C, Woods WE, Tai H-H, Blake JW, Tobin T:  A review of the pharmacology and detection of fentanyl and its congeners in the horse.  Proc 41st Meeting Assoc of Racing Chem., 1987, Los Angeles, CA, pp287-313.

166. Yang J-M, Tai CL, Weckman TJ, Tai H-H, Blake JW, Tobin T, McDonald J, Gall R,   Wiedenback P, Bass VD, Brockus C, Stobert D, Wie S, Prange CA:  Immunoassay detection of drugs in horses. II. Detection of carfentanil in equine urine by RIA, PCFIA and ELISA.         Res Commun Subst Abuse, 8(2):59-75, 1987.

167. Kamerling S, Weckman TJ, Tobin T:  Dose related effects of kappa agonist U-50,488H on behavior, nociception and autonomic response in the horse. Eq Vet J, 20(2):114-118,1988.

168. Kwiatkowski S, Sturma L, Dai MR, Tai H-H, Watt DS, Tai CL, Woods WE, Weckman TJ, Yang J-M, Wood TW, Chang S-L, Blake JW, Tobin T, Prange C, Brockus C, Stobert D, Wie, Chung RA, McDonald J, Bass VD, Merchant S, Artemenko M: Immunoassay detection of drugs in racing horses. VII. Detection of acepromazine in equine blood and urine by ELISA and PCFIA.  Res Comm Chem Path Pharmacol, 61(3):391-412, 1988.

169. McDonald J, Gall R, Wiedenback P, Bass VD, DeLeon B, Brockus C, Stobert D, Wie S, Prange CA, Ozog FJ, Green MT, Woods WE, Tai CL, Dai MR, Weckman TJ, Tai H-H, Yang J-M, Chang S-L, Blake JW, Tobin T:  Immunoassay detection of drugs in horses.  III. Detection of morphine in equine blood by a one step ELISA assay.  Res Commun Chem Path Pharmacol, 59(2):259-278, 1988.

170. McDonald J, Watt DS, Kwiatkowski S, Tai H-H, Wie S, Prange CA, Wood T, Tobin T: Immunoassay based pre-race testing:  An effective pre-race testing system. In: Breccia A (ed), Il Controllo Antidoping dei Cavalli da Corsa (Proc Int’l Seminar Tech Pharmacol Legal Aspects Antidoping Control Racehorses).  Bologna, Italy, October, 1988, pp 43-52 (145-157).

171. Prange CA, Brockus C, Stobert D, Wie S, McDonald J, Gall R, Wiedenbach P, Bass  VD, DeLeon B, Ozog FJ, Green MT, Woods WE, Tai CL, Dai MR, Weckman TJ, Tai H-H, Yang J-M, Chang S-L, Blake JW, Tobin T:  Immunoassay detection of drugs in racing horses. V. Detection of mazindol in equine blood and urine by a one step ELISA assay.  Res Comm Subst Abuse, 9(1):13-30, 1988. 

172. Prange CA, Wie S, Brockus CL, Dahl, PA, Lewis EL, Brecht JM, Conner JC, Chung RA, McDonald J, Bass VD, Merchant S, Kwiatkowski S, Woods WE, Watt DS, Tai H-H, Blake JW, Chang S-L, Tobin T: Screening for human drugs of abuse by particle concentration fluorescence immunoassay (PCFIA).  Res Comm Subst Abuse, 9(3,4):129-155, 1988.

173. Sturma L, Tai H-H, Tai CL, Tobin T, McDonald J, Wie S, Prange CA, Ozog FJ:  ELISA detection of morphine in the horse.  Proc 7th Int’l Confer Racing Analysts Vets, Louisville, KY, April 1988, 145-153.

174. Tai CL, Wang C-J, Weckman TJ, Popot MA, Woods WE, Yang J-M, Blake JW, Tai H-H, Tobin T:  Radioimmunoassay for etorphine in horses with a 125I analog of etorphine.  Am J Vet Res, 49(5):622-628, 1988.

175. Tobin T, Galley RH:  Drugs and performance.  Chapter 11 in Jones WE (ed), Equine Sports Medicine.  Lea and Febiger, Philadelphia, 1988, pp 189-204.

176. Tobin T, McDonald J, Ozog FJ, Prange CA:  Enzyme linked immunosorbent assay (ELISA): A revolution in equine drug testing.  Equine Veterinary Data, 9(2):19-31, 1988.

177. Tobin T, Stanley SD, Kwiatkowski S, Watt DS, Tai H-H, McDonald J, Prange CA:  ELISA based immunoassay tests in post-race testing. In: Breccia A (ed), Il Controllo Antidoping dei Cavalli da Corsa (Proc Int'l Seminar Tech Pharmacol Legal Aspects Antidoping Control Racehorses). Bologna, Italy, October, 1988, pp 85-104 (163-184).

178. Tobin T, Tai H-H, Tai CL, Houtz PK, Dai MR, Woods WE, Weckman TJ, Yang J-M, Chang S-L, Blake JW, McDonald J, Gall R, Wiedenbach P, Bass VD, DeLeon B, Ozog FJ, Green MT, Brockus C, Stobert D, Wie S, Prange CA:  Immunoassay detection of drugs in horses. IV. Detection of fentanyl in equine blood and urine by a one step ELISA assay.  Res Comm Chem Path Pharmacol, 60(1):97-115, 1988.

179. Tobin T, Watt DS, Kwiatkowski S, Tai H-H, Blake JW, McDonald J, Kalita S, Prange CA, Wie S:  Non-isotopic immunoassay drug tests in racing horses: A review of their application to pre-and post-race testing, drug quantitation, and human drug testing.  Res Comm Chem Path Pharm, 62(3):371-395, 1988.

180. Tobin T, Wood T:  The effects of drugs on race horse performance. Proc 34th Convent Am Assoc. Equine Pract, San Diego, CA, Dec, 1988, pp 639-650.

181. Weckman TJ, Tobin T, Tai H-H, Yang J-M, Wie S, Prange CA, Ozog FJ:  ELISA and RIA detection of fentanyl in the horse.  Proc 7th Int’l Confer Racing Analysts Vets, Louisville, KY, April 1988, 123-133.

182. Wood T, Tai CL, Henry P, Woods WE, Tobin T, Wie S, Prange CA, McDonald J, Ozog FJ, Green MT:  The detection of furosemide in equine blood by fluorescence and enzyme-linked immunoassays.  Proc 7th Int’l Confer Racing Analysts Vets, Louisville, KY, April 1988, 113-122.

183. Wood TW, Weckman TJ, Woods WE, Tobin T, Dougherty J:  Detomidine: A preliminary analysis of its duration of action in the horse by variable interval responding.  Eq Vet J, 20(5):320-322, 1988.

184. Wood T, Weckman TJ, Henry P, Chang S-L, Blake JW, Tobin T: Parameters of equine urine pH and methods of acidification.  Proc 7th Int’l Confer Racing Analysts Vets, Louisville, KY, April 1988, 259-265.

185. Woods WE, Wang C-J, Houtz PK, Tai H-H, Wood TW, Weckman TJ, Yang J-M, Chang S-L, Blake JW, Tobin T, McDonald J, Kalita S, Bass VD, Weege P, DeLeon B, Brockus C, Wie S, Chung RA, Brecht J, Conner J, Dahl P, Lewis E, Prange CA, Ozog FJ, Green M: Immunoassay detection of drugs in racing horses. VI.  Detection of furosemide (Lasix®) equine blood by a one step ELISA and PCFIA.  Res Comm Chem Path Pharmacol, 61(1): 111-128, 1988.

186. Yang J-M, Tobin T, Dai M-R, Watt D, Kwiatkowski S, Tai H-H, Sturma L, Wie S, Prange CA, McDonald J, Ozog FJ:  ELISA detection of acepromazine in the horse.  Proc 7th Int’l Confer Racing Analysts Vets, Louisville, KY, April 1988, 155-160.

187. Yang J-M, Woods WE, Weckman TJ, Wood TW, Chang S-L, Blake JW, Tobin T:  The pharmacology, pharmacokinetics, and behavioral effects of diisopropylamine dichloroacetate (DADA) in the horse: A preliminary report.  Gen Pharmacol, 19(5):683-688, 1988.

188. Blake JW, Woods WE, Goodman JP, Tobin T:  Pre- and post-race testing for drugs in racing horses. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp.  115-124, 1989.

189. Kamerling S, Wood TW, DeQuick D, Weckman TJ, Tai C, Blake JW, Tobin T: Narcotic analgesics, their detection and pain measurement in the horse: A review. Eq Vet J, 21(1):4-12, 1989.

190. Kwiatkowski S, Goodman JP, Stanley SD, Yang J-M, Wood T, Sturma L, Woods WE, Tian Z-G, Bertram S, Tai H-H, Weckman TJ, Chang S-L, Blake JW, Watt DS, Tobin T, McDonald J, Wie S, Chung RA, Brecht JM, Conner JC, Dahl PA, Lewis EL, Prange CA: Immunoassay detection of drugs in racing horses. X. Detection of phenylbutazone in equine blood and urine by particle concentration fluoroimmunoassay. Res Comm Subst Abuse, 10(2):123-139, 1989.

191. Kwiatkowski S, Tobin T, Watt DS:  A synthesis of N-substituted á-alanines: Michael addition of amines to trimethylsilylacrylate.  Synthesis, 946-949, 1989.

192. Prange CA, Brockus C, Wie S, Chung RA, Brecht JM, Conner JC, Dahl PA, Lewis EL, McDonald J, Kalita S, Kwiatkowski S, Goodman JP, Sturma L, Stanley SD, Yang J-M, Wood T, Henry P, Weckman TJ, Woods WE, Watt DS, Tai H-H, Chang S-L, Blake JW, Tobin T:  Immunoassay detection of drugs in racing horses.  VIII. Detection of cocaine in equine blood and urine by particle concentration fluorescence immunoassay.  Res Comm Subst Abuse, 10(1):1-14, 1989.

193. Stanley S, Tobin T, Wood T:  The effects of steroids in racing horses.  Pacemaker Update International, 2: 48, 1989.

194. Tobin T:  Non-steroidal anti-inflammatory drugs: Phenylbutazone and others. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, , pp. 13-21, 1989.

195. Tobin T:  The effects of drugs on equine performance and the use of ELISA tests in equine medication control. [Presented at Cong Wrld Equine Vet Assoc. (Equitana), Essen, West Germany, 1989.]  J Eq Vet Sci, 9 (3): 160-168, 1989.

196. Tobin T:  Tranquilizers, analgesics and local anesthetics.  Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 179-187, 1989.

197. Tobin T, Kwiatkowski S, Watt DS, Tai H-H, Tai CL, Woods WE, Goodman JP, Taylor DG, Weckman TJ, Yang J-M, Tai JD, Stanley SD, Wood T, Chang S-L, Blake JW, McDonald J, Wie S, Prange CA, Uboh CE:  Immunoassay detection of drugs in biological samples:  XI. ELISA and RIA detection of fentanyl, alfentanil, sufentanil and carfentanil in equine blood and urine.  Res Comm Chem Pathol Pharmacol, 63(1):129-152, 1989.

198. Tobin T, Stanley SD:  Anabolic steroids: use and excretion data. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 150-157, 1989.

199. Tobin T, Wood T:  Passing the test: Immunoassay tests proving fast, reliable in detecting equine drugging.  Horseman and Fair World, 9, 52-54, 1989.

200. Tobin T, Woods WE:  Detection times and clearance times for drugs in racing horses. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp.  105-113, 1989.

201. Tobin T, Woods WE: Medication for exercise-induced pulmonary hemorrhage and its effects on other medications.  Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 134-141, 1989.

202. Tobin T, Woods WE:  Narcotics and stimulants: how they affect horses. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 49-59,1989.

203. Tobin T, Woods WE:  Steroidal anti-inflammatory agents and adrenocorticotropic hormone.  Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp.  23-30, 1989.

204. Weckman TJ, Woods WE, Wood TW, Tai C, Tai H-H, Blake JW, Tobin T:  Pharmacologic effects and detection methods of methylated analogs of fentanyl in horses.  Am J Vet Res, 50(4):502-507, 1989.

205. Wood T, Stanley SD, Tobin T:  Operant conditioning and its applications in equine pharmacology.  J Equine Vet Sci, 9(3): 124-130, 1989.

206. Wood T, Tai CL, Taylor DG, Woods WE, Wang C-J, Houtz PK, Tai H-H, Weckman TJ, Yang J-M, Sturma L, Chang S-L, Goodman JP, Stanley SD, Blake JW, Watt DS, Tobin T, McDonald J, Wie S, Chung RA, Brecht JM, Conner JC, Dahl PA, Lewis EL, Prange CA: Immunoassay detection of drugs in racing horses. IX. Detection of detomidine in equine blood and urine by radioimmunoassay.  Res Comm Chem Path Pharm, 63(2):263-279, 1989.

207. Frank M, Weckman TJ, Wood TW, Woods WE, Tai C, Chang S-L, Ewing A, Blake JW, Tobin T:  Hordenine: Pharmacology, pharmacokinetics and behavioural effects in the horse. Eq Vet J, 22(6):437-441, 1990.

208. Jeganathan A, Park S, Kwiatowski S, Yang J, Stanley S, Woods WE, Tobin T, Tai H-H, Blake JW, Watt D:  The development of a generic fentanyl ELISA test.  Proc 43rd Meeting Assoc. Official Racing Chem, 87, 1990.

209. Stanley S, Tai C, Goodman J, Taylor D, Wood T, Woods WE, Yang JM, Kwiatowski S, Tai H-H, Blake JW, Henry P, Chang S-L, Tobin T:  Immunoassay detection of drugs in racing horses.  Detection of reserpine in equine blood and urine by a one step ELISA.  Submitted to Fun App Tox, 1990.

210. Tobin T, Blake JW, Potter M, Wood TW (eds):  Proc 7th Int’l Conf Racing Analysts Vets, Lexington, KY, 516 pages, 1990.

211. Tobin T, Wood T:  ELISA testing in race horses.  Proc. Unione Nazionale L'Incremento Delle Razze Equine.  Rome Italy, 1990.

212. Wood TW, Weckman TJ, Henry PA, Chang S-L, Blake JW, Tobin T: Equine urine pH: Normal population distribution and methods of acidification.  Eq Vet J, 22(2):118-121, 1990.

213. Stanley SD, Jeganathan A, Wood TW, Henry PA, Turner S, Woods WE, Green MT, Tai H-H, Watt DS, Blake JW, Tobin T:  Morphine and etorphine:  Detection by ELISA in equine urine.  J Analytical Tox, 15(6):305-310, 1991.

214. Stanley SD, Woods WE, Elliott D, Chen P-L, Ravard A, Tai H-H, Watt DS, Gerken DF, Sams RA, Tobin T:  Immunoassay detection of drugs in racing horses.  XIX. Detection of benzoylecgonine/cocaine in equine urine by ELISA.  Proc 44th Meeting Assoc. Official Racing Chem, Cincinnati, OH, pp. 218-228, 1991.

215. Tobin T:  Detection times and clearance times for drugs in racing horses.  (Lecture Presentation, Paper from Bain Fallon Lectures)  Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 31-37, 1991.

216. Tobin T:  Medication for exercised-induced pulmonary haemorrhage and its effects on other medications.  (Lecture Presentation, Paper from Bain Fallon Lectures)  Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 43-47, 1991.

217. Tobin T:  Narcotics and stimulants: How they affect horses.  (Lecture Presentation, Paper from Bain Fallon Lectures)  Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 25-31, 1991.

218. Tobin T:  Non-steroidal anti-inflammatory drugs: Phenylbutazone and others.  (Lecture Presentation, Paper from Bain Fallon Lectures)  Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 13-19, 1991.

219. Tobin T:  Pre- and post-race testing for drugs in racing horses.  (Lecture Presentation, Paper from Bain Fallon Lectures)  Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 37-43, 1991.

220. Tobin T:  Steroidal anti-inflammatory agents and adrenocorticotropic hormone.  (Lecture Presentation, Paper from Bain Fallon Lectures)  Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 19-25, 1991.

221. Tobin T:  Tranquilizers, analgesics and local anaesthetics.  (Lecture Presentation, Paper from Bain Fallon Lectures)  Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 47-59, 1991.

222. Wood T, Terhune T, Dunigan C, Goodman JP, Turner S, Blake JW, Stanley SD, Tobin T:  Clearance times and the forensic significance of the dietary anthelmintic pyrantel tartrate in performance horses.  J Eq Vet Sci., 11(4):220-224, 1991.

223. Roth L, Harbison RD, James RC, Tobin T, Roberts SM. Cocaine hepatotoxicity: influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis. Hepatology. 15(5):934-40, 1992.

224. Smith JD, Arthur R, Barton J, Bowen E, Byars D, Derksen F, Erickson H, Gowen B, Hinchcliff KW, Manohar M, O'Callaghan M, Pascoe J, Robinson E, Sams RA, Soma LR, Sweeney C, Tobin T:  Exercise-induced pulmonary hemorrhage findings, Proc of Workshop, Part I.  Equine Pract, 14(1):19-25, 1992.

225. Smith JD, Arthur R, Barton J, Bowen E, Byars D, Derksen F, Erickson H, Gowen B, Hinchcliff KW, Manohar M, O'Callaghan M, Pascoe J, Robinson E, Sams RA, Soma LR, Sweeney C, Tobin T:  Exercise-induced pulmonary hemorrhage findings, Proc of Workshop, Part II.  Equine Pract, 14(2):9-15, 1992.

226. Smith JD, Arthur R, Barton J, Bowen E, Byars D, Derkson F, Erickson H, Gowen B, Hinchcliff KW, Manohar M, O'Callaghan M, Pascoe J, Robinson E, Sams RA, Soma LR, Sweeney C, Tobin T:  Exercise-induced pulmonary hemorrhage findings, Proc of Workshop, Part III.  Equine Pract, 14(3):28-31, 1992.

227. Stanley SD, Dressler R, Woods WE, Langemeier J, Goodman JP, Pyrek J, Wood TW, Tobin T: The dietary anthelmintic pyrantel tartrate: An analysis of its detection times in geldings, mares and stallions.  Short CR (ed) Proc 9th Int’l Conf Racing Analysts Vets, New Orleans, LA, 1992, pp 321-326.

228. Stanley SD, Yang J-M, Wood TW, Selonen JS, Watt DS, Tai H-H, Tobin T:  Detomidine clearance in the horse as determined by ELISA.  Short CR (ed) Proc 9th Int’l Conf Racing Analysts Vets, New Orleans, LA, 1992, pp 193-201.

229. Stanley S, Yang J, Wood T, Yusufji A, Watt D, Tai H-H, Tobin T:  ELISA testing: Backgrounds in equine urine, test sensitivity, sample pooling and significance of number of tests.  Proc 45th Meeting Assoc Official Racing Chem 308-326, 1992.

230. Stoilov I, Watt S, Cynkowska G, Goodman JP, (Tobin T), St Pyrek J:  Development of a mass spectral confirmation scheme for the carboxylic acid metabolites of detomidine and medetomidine in horse urine.  Submitted to Analytical Toxicology, 1992.

231. Tobin T:  Kentucky Laboratory takes lead against horse dopers.  Clin Chem News, 18, pages 1-11, 1992.

232. Wood TW, Stanley SD, Woods WE, Henry PA, Watt DS, Tobin T: Evaluation of threshold doses of drug action in the horse using hematocrit values as an indicator.  Res. Comm. Chem. Path. Pharmacol, 75(2):231-241, 1992.

233. Woods, WE, Stanley DS, Yang J-M, Cook D, Gerkin DF, Detra RL, Sams RA, Jeganathan A, Watt DS, Tai H-H, Tobin T:  ELISA detection of azaperone in the racehorse.  Short CR (ed) Proc 9th Int’l Conf Racing Analysts Vets, New Orleans, LA, 1992, pp 187-192.

234. Yang J-M, Stanley DS, Woods WE, Cook D, Hirsch R, Wood TW, Sams RA, Tai H-H, Watt DS, Tobin T:  Development of an ELISA for procaine in racing horses and dogs. Short CR (ed) Proc 9th Int’l Conf Racing Analysts Vets, New Orleans, LA, 1992, pp 377-384.

235. Harkins JD, Carney JM, Tobin T:  Clinical use and characteristics of the corticosteroids.  Hinchcliff KW, Sams RA (eds), Vet Clin N Amer:  Equine Practice, Drug Use in Performance Horses, Vol 9, Saunders, Philadelphia, 1993, pp 543-562.

236. Stanley SD, Gairola CG, Diana JN, Huffman M, Sadove RC, Woods WE, Kwiatkowski S, Tai H-H, Tobin T: Development and characterization of an ELISA for cotinine in biological fluids.  Inhalation Toxicology, 5(4): 403-413, 1993.

237. Harkins JD, Mundy GD, Woods WE, Rees WA, Thompson KN, Tobin T:  Determination of the local anesthetic efficacy of procaine, cocaine, bupivacaine and benzocaine.  Proc 10th Int’l Conf Racing Analysts Vets, Stockholm, Sweden, p. 303-306, 1994.

238. Queiroz-Neto A, Tobin T: Interpretação resultados positivos para cocaína e cafeína em amostras de cavalos de corrida.  Revista Brasileira de Toxicologia, 7(1/2) p. 5-10, 1994.  [KY Ag Exp Sta #95-14-056]

239. Kellon EM, (in consultation with) Tobin T:  Equine Drugs and Vaccines:  A Guide for Owners and Trainers.  Breakthrough Press, Ossining, NY, 1994, 336 pp.

240. Stanley S, Wood T, Goodman JP, Henry PA, Woods, WE, Chang S-L, Tai H-H, Watt D, Kwiatkowski S, Blake JW, Tobin T:  Immunoassay detection of drugs in racing horses:  Detection of ethacrynic acid and bumetanide in equine urine by ELISA.  J Analytical Tox, 18: 95-100, 1994.

241. Tobin T:  Interim report on the workshop:  Testing for Therapeutic Medications, Environmental and Dietary Substances in Racing Horses, Univ of Kentucky, Lexington, KY, 1994.

242. Hall NC, Yang J-M, Stanley SD, Mundy GD, Kryscio R, Tai H-H, Blake JW, Woods WE, Tobin T: Number of negative tests required to exclude specific levels of agent abuse in equine forensic chemistry.  Submitted to Equine Practice, 1995.

243. Harkins JD, Stanley SD, Mundy GD, Carney JM, Sams RA, Woods WE, Tobin T:  A  review of the Pharmacology, pharmacokinetics, and regulatory control in the US of local anesthetics in the horse.  J Vet Pharmacol Therap, 18: pp 397-406, 1995.

244. Harkins JD, Tobin T:  A review of the methodologies used to determine the highest no-effect doses (HNEDs) for medications in horses.  Proc Testing Therap Med Environ Diet Subst Racing Horses, Lexington, KY, 1995, pp 169-174.

245. Harkins JD, Tobin T:  Racing horses, nitroglycerin and exercise-induced pulmonary hemorrhage.  Equine Vet J, 27(4):240-241, 1995.

246. Sendlein LVA, Birge WJ, Blomquist GC, Dinger JS, Huffsey RR, Horstman SW, Kercher MD, McGinley P, Short DC, Struttman T, Taylor L, Tobin T, Dunn D, Naugle BI:  Final summary report:  Identification of appropriate standards for corrective action for a release from petroleum underground storage tanks.  Submitted to Petroleum Underground Storage Tank Environmental Assurance Fund Commission, 1995.

247. Rees WA, Chambers TM, Fenger CK, Harkins JD, Blouin RA, Holland RE, Tobin T:  Pharmacokinetics and bioavailability of amantadine in the horse.  Proc 41st Convent Am Assoc. Equine Pract, Lexington, KY, 1995, pp270-271.

248. Harkins JD, Mundy GD, Stanley SD, Woods We, Rees WA, Thompson KN, Tobin T:  Determination of highest no-effect doses (HNEDs) for local anesthetic responses to procaine, cocaine, bupivacaine, and benzocaine in Thoroughbred mares.  Proc 41st Convent Am Assoc. Equine Pract, Lexington, KY 1995, pp163-165.

249. Stanley SD, Sams RA, Harkins JD, Mundy GD, Boyles J, Woods WE, Tobin T:  Frequency distribution of post-race urine pH from thoroughbreds and standardbreds:  Research and regulatory significance.  Equine Vet J, 27:471-473, 1995.

250. Tobin T:  Fifties rules, nineties testing:  The need for thresholds for therapeutic medications.  Racing Update, 18 (10):89-92, 1995.

251. Tobin T, Harkins JD:  Thresholds for high potency drugs:  Plasma or urinary thresholds?  Proc Testing Therap Med Environ Diet Subst Racing Horses, Lexington, KY, 1995, pp 185-189.

252. Tobin T, Harkins JD, Woods WE, Hall NC, Queiroz-Neto A, Stanley SD, Mundy GD:  Testing for drugs, medications and other substances in racing horses.  Proc for the Short Course: Recent Advances in Equine Nutrition, Kentucky Equine Research, Inc., Versailles, KY, 1995, pp 1-26.  [KY Ag Exp Sta #95-14-057]

253. Harkins JD, Stanley S, Mundy GD, Sams RA, Woods, WE, Rees WA, Thompson K, and Tobin T:  Determination of Highest No-Effect Doses (HNEDs) for local anesthetics.  Proc 41st Convent Am Assoc. Equine Pract, pp 163-165, 1995.

254. Harkins JD, Stanley S, Mundy GD, Sams RA, Woods WE, Arthur R, Boyles J, and Tobin T:  Significance of Procaine residues in post race urine samples.  Proc 41st Convent Am Assoc. Equine Pract, pp 168-169, 1995.

255. Harkins JD, Stanley S, Mundy GD, Sams RA, Woods WE, Richardson DR, and Tobin T:  Character and duration of pharmacological effect of isoxsuprine.  Proc 41st Convent Am Assoc. Equine Pract, pp 166-167, 1995.

256. Tobin T, Mundy GD, Stanley SD, Sams RA, Crone D (eds): Testing for Therapeutic Medications, Environmental and Dietary Substances in Racing Horses, Proceedings of Workshop, Lexington, KY, 220 pages, 1995.  [KY Ag Exp Sta #95-14-058]

257. Sams RA, Gerkin, DF, Detra RL, Wood WE, Stanley SD, Tobin T, Yang J-M, Tai H-H, Jegananthan A, Watt DS:  Identification of metabolites of azaperone in horse urine, J Pharm Sci. 85 pp 79-84, 1996.

258. Stanley DS, Mundy GD, Woods WE, Harkins JD, Rees WA, Boyles J, Sams RA, Tobin T:  ELISA detection of cocaine and cocaine metabolites in equine urine, saliva and serum.  Manuscript in progress, 1996.

259. Harkins JD, Mundy GD, Stanley SD, Woods WE, Rees WA, Thompson KN, Tobin T:  Determination of highest no-effect doses (HNEDs)for the local anesthetic responses to procaine, cocaine, bupivacaine and benzocaine.  Equine Vet J, 28:30-37, 1996.

260. Harkins JD, Mundy GD, Stanley SD, Woods WE, Sams RA, Richardson DR, Tobin T:  Character and duration of pharmacologic effects of intravenous isoxsuprine.  Equine Vet J, 28(4):320-326, 1996.

261. Harkins JD, Mundy GD, Stanley SD, Woods WE, Boyles J, Arthur RA, Sams RA, and Tobin T:  Regulatory significance of procaine residue in plasma and urine samples:  Preliminary communication, Equine Vet J, 28(2), 121-125, 1996.

262. Edgar T, Tobin T, Watt D, Tai H-H, Schroedter D, Ice JT, Bass S: ELISA assay for caffeine. Proc 11th Intl'n Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 478-480.

263. Harkins JD, Queiroz-Neto A, West D, Mundy GD, Tobin T: Quantitation of the locomotor effect of therapeutic medication in a behavior chamber.  Proc 11th Intl'n Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 117-120.

264. Edgar T, Tobin T, Tai H-H, Bass S, Ice JT, Schroedter D: ELISA assay for flunixin. Proc 11th Int’l Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 466-469.

265. Edgar T, Tobin T, Tai H-H, Bass S, Ice JT, Schroedter D: ELISA assay for methocarbamol. Proc 11th Int’l Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp.459-462.

266. Stanley SD, Troppmann A, Carter W, Sams RA, Harkins JD, Mundy GD, Boyles J, Woods WE, Tobin T: Frequency distributions of pH values in post-race urine samples from Standardbred and Thoroughbred horses. Proc 11th Int’l Conf  Racing Analysts Vets, Brisbane, Australia, 1996, pp 442-444.

267. Foster CN, Boyles J, Crone DL, Mundy GD, Sams RA, Stanley SD, Tobin T: Response to a survey among international racing authorities on therapeutic medications, environmental and dietary substances in racehorses. Proc 11th Int’l Conf Racing Analysts Vets, Brisbane, Australia,1996, pp 46-55.

268. Rees WA, Harkins JD, Woods WE, Blouin RA, Lu M, Fenger C, Holland RE, Tobin T, Chambers TM: Chemotherapy for equine influenza: Overview of the pharmacology and side effects of amantadine and rimantadine in the horse.  Proc 11th Int’l Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 355-357.

269. Rees WA, Kwiatkowski S, Stanley SD, Granstrom DE, Yang J-M, Gairola CG, Drake D, Glowczyk J, Woods WE, Tobin T: The development and characterization of an ELISA for trans-3'-hydroxycotinine, a biomarker for mainstream and sidestream smoke exposure. Bengston DA, Henshel DS (eds), Environmental Toxicology and Risk Assessment: Biomarkers and Risk Assessment (5th Vol), Am Soc Testing Materials, Philadelphia, 1996, pp 149-162. [KY Ag Exp Sta #92-4-167]

270. Woods WE, Mundy GD, Stanley SD, Sams RA, Harkins JD, Carter W, Boyles J, Rees WA, Bass S, Tobin T:  Detection and quantification of cocaine and its metabolites in equine body fluids after administration by different routes.  Proc 11th Int’l Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 503-507. [KY Ag Exp Sta # 96-14-080]

271. Harkins JD, and Tobin T:  The pharmacologic effects of isoxsuprine.  Pferdeheilkunde, 12: 428-430, 1996.

272. Harkins JD, Smith RA, Tobin T: Poisonous plants and feed related poisoning in horses. The Veterinarian’s Practical Reference to Equine Nutrition, 135-165, 1997.

273. Harkins JD, Tobin T, Mundy GD, Harrison L, Poonacha KB:  Exercise-induced pulmonary hemorrhage:  A Review of the etiology and pathogenesis.  Equine Pract., 19 (1):  22-28, 1997. [KY Ag Exp Sta # 95-14-182]

274. Rees WA, Harkins JD, Woods WE, Blouin RA, Chambers T, Carter WG, Holland R, Fenger C, Tobin T: Amantadine and equine influenza:  Pharmacology, pharmacokinetics and neurological effects in the horse. Equine Vet J, 29(2): 104-110, 1997. [KY Ag Exp Sta #95-14-134]

275. Harkins JD, Mundy GD, Stanley SD, Sams RA, Tobin T: Lack of  local anesthetic efficacy of Sarapin in an abaxial sesamoid block model. J Vet Pharmacol Therap 20, 229-232, 1997.

276. Sleeman JM, Carter WG, Tobin T, Ramsay EC; Immobilization of domestic goats (Captra hircus) using orally administered carfentanil citrate and detomidine HCL.  J Zoo Wildlife Med, 28 (2):  158-165, 1997.

277. Harkins JD, Mundy GD, Stanley S, Woods WE, Lehner A. Rees WA, Dirikolu L, Bass S, Karpiesiuk W, Carter WG, Boyles J, Tobin T:  Lidocaine in the horse:  Its pharmacological effects and their relationship to analytical findings.  J Vet Pharmacol Therap 21:462-476, 1998.

278. Tobin T, Mundy GD, Stanley SD, Sams R, Jack RA:  The Commission Veterinarian Equine Medical Director:  A Short Course, Nov. 28- Dec. 1, 1995. In Preparation for Publ. 1997.

279. Harkins JD, Carney JM, Meier M, Laek SC, Tobin T:  Effect of a-phenyl-tert-butylnitrone on endotoxin toxemia in horses.  Vet Human Toxicol 39 (5) October 1997:  pp 268-271. [KY Ag Exp Sta #95-14-077]

280. Queiroz-Neto A, Zamur G, Goncalves SC, Carregaro AB Mataqueiro MI, Harkins JD,  Tobin T:  Characterization of the antinociceptive and sedative effect of amitraz in horses.  J Vet Pharmacol Therap, 21(5):400-405, 1997. [KY Ag Exp Sta #97-14-137].

281. Tobin T, Mundy GD, Rees WA, Harkins JD, Woods WE, Lehner A, Karpiesiuk W, Dirikolu, Boyles J, Carter W:  Review of a consequence of highly sensitive drug testing:  The need for data on analytical-pharmacological relationships for therapeutic medication.  Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp 215-219.

282. Granstrom DE, McCrillis S, Wulff-Strobel C, Baker CB, Carter W, Harkins JD, Tobin T, Saville WJ:  Diclazuril and equine protozoal myeloencephalitis.  Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp13-14.

283. Tobin T, Dirikolu L, Harkins JD, Granstrom DE, Carter W, Lehner A, Rees WA:  Preliminary pharmacokinetics of diclazuril and toltrazuril in the horse.  Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp15-16.

284. Harkins JD, Tobin T, Queiroz-Neto A:  Development of an equine behavior chamber and effects of amitraz, detomidine and acepromazine on spontaneous locomotor activity. Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp227-228.

285. Queiroz-Neto A, Zamur G, Carregaro AB, Mataqueiro MI, Salvadori MC, Azevedo CP, Harkins JD, Tobin T:  Effects of caffeine on locomotor activity of horses: Determination of the no-effect threshold. J Applied Toxicol, 21:229-234, 2001.

286. Rees WA, Holland RE, Dirikolu L, Tobin T, Chambers TM:  Therapeutic efficacy of rimantadine HCl in experimentally induced influenza: An illness in horses. Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp390-391.

287. Harkins, JD, Mundy GD, Karpiesiuk W, Woods WE, Dirikolu L, Carter WG, Boyles J, Tobin T:  Bupivacaine:  Pharmacological effects, analytical detection, and regulatory significance in performance horses.  In press, 1999.

288. Woods WE, Lehner A, Karpiesiuk W, Harkins JD, Tobin T:  Detection and quantitation of 3-hydroxymepivacaine in horse urine.  Proc 12th Intl’n Conf Racing Analysts Vets, Vancouver, Canada, 1998, pp324-328. [KY Ag Exp Sta #98-14-35].

289. Harkins JD, Mundy GD, Stanley SD, Woods WE, Sams RA, Richardson DR, Grambow SC, Tobin T: Absence of detectable pharmacological effects after oral administration of isoxsuprine. Equine Vet J 30(4):294-299, 1998. [KY Ag Exp Sta #96-14-142].

290. Lehner A, Woods WE, Harkins JD, Karpiesiuk W, Boyles J, Carter WG, Dirikolu L, Tobin T:  Detection and quantitation of 3-hydroxybupivacaine in horse urine.  Proc 12th Intl’n Conf Racing Analysts Vets, Vancouver, Canada, 1998, pp287-291. [KY Ag Exp Sta #98-14-48]

291. Harkins JD, Karpiesiuk W, Woods WE, Lehner A, Mundy GD, Rees WA, Dirikolu L, Bass S, Carter WG, Boyles J, Tobin T:  Mepivacaine:  Its pharmacological effects and their relationship to analytical finding in the horse.  J. Vet. Pharmacol. Therap, 22:107-121, 1999. [KY Ag Exp Sta #98-14-148].

292. Tobin T:  Medication control from 1900 to the Present.  HBPA Medication Booklet, 1998, pp. 23-29. [KY Ag Exp Sta #97-14-138].

293. Rees WA, Harkins JD, Lu M, Blouin RA, Holland RE, Lehner F, Chambers TM, Tobin T: Rimantadine and equine influenza: Pharmacology, pharmacokinetics, and therapeutic efficacy in the horse.  Equine Vet J, 29(2):104-110, 1996. [KY Ag Exp Sta #95-14-134].

294. Harkins JD, Mundy GD, Stanley SD, Rees WA, Tobin T: An overview of the methylxanthines and their regulation in the horse.  Equine Practice, 20(1):10-16, 1998.  [KY Ag Exp Sta #96-14-084].

295. Karpiesiuk W, Lehner A, Woods WE, Tobin T: Equine drug metabolites and standards.  Distributed, 1998.  Booklet published by Gluck Equine Research Center, Lexington, KY, 1998.

296. Tobin T, Lehner A, Woods WE, Karpiesiuk W, Harkins JD: Detection and quantitation of 3-hydroxylidocaine in horse urine.  In press, Proc 12th Int’l Conf Racing Analysts Vets, Vancouver, Canada, 1998.

297. Dirikolu L, Lehner A, Woods WE, Bentz B, Harkins JD, Carter W, Granstrom DE, Tobin T: Detection, quantification and preliminary pharmacokinetics of diclazuril in the horse.  Proc 12th Int’l Conf Racing Analysts Vets, Vancouver, Canada, 1998, pp240-244. [KY Ag Exp Sta #98-14-39].

298. Tobin T, Saville W, Carter W, Cohen N, Divers T:  The interim report on workshop on equine protozoal myeloencephalitis:  Testing and treatment.  Manuscript distributed to workshop participants, 1998. [KY Ag Exp Sta #98-14-42].

299. Dirikolu L, Lehner AF, Nattrass C, Bentz B, Woods WE, Carter W, Karpiesiuk W, Boyles J, Harkins JW, Granstrom DE, Tobin T: Diclazuril in the horse: Its identification, detection and preliminary pharmacokinetics. J Vet Pharm Therap, 22:374-379, 1999. [KY Ag Exp. Sta #98-14-70].

300. Tobin T, Harkins JD, Sams RA: Testing for therapeutic medications: Analytical/pharmacological relationships and the need for “limitations” on the sensitivity of testing for certain agents.  J Vet Pharm Therap, 22:220-233. 1999. [KY Ag Exp Sta #98-14-134].

301. Harkins JD, Tobin T:  Lack of local efficacy of fentanyl in the abaxial sesamoid block model.   J Vet Pharm Therap, 22:52-55, 1999 [KY Ag Exp Sta #98-14-85].

302. Heller TA, Tobin T, Karpiesiuk W, Tai H-H, Harkins JD, Magsig SE, Schroedter DE: ELISA assay for fluoxetine.  In press, Proc 12th Int’l Conf Racing Analysts Vets, Vancouver, Canada, 1998.

303. Bentz BG, Dirikolu L, Carter WG, Saville W, Bernard WV, Wulff-Strobel C, McCrillis S, Reed S, Granstrom DE, Tobin T: Clinical report on diclazuril and equine protozoal myeloencephalitis (EPM). Equine Vet. Education, 2:258-263, 2000 [KY Ag Exp Sta #98-14-159].

304. Bentz BG, Carter WG, Tobin T: Equine protozoal myeloencephaltis (EPM):  Review of a diagnostic approach.  Compendium on Continuing Education for Practicing Veterinarians, 21:975-981, 1999. [KY Ag Exp Sta #98-14-158].

305. Harkins JD, Karpiesiuk W, Tobin T, Dirikolu L, Lehner AF:  Identification of hydroxyropivacaine glucuronide in equine urine by ESI+/MS/MS.  Can J Vet Res, 64(3):178-183. [KY Ag. Exp. Sta#98-14-151].

306. Short CR, Sams RA, Soma LR, Tobin T:  The regulation of drugs and medicines in horse racing in the United States.  The Association of Racing Commissioners International Uniform Classification of Foreign Substances Guide.  J Vet Pharm Therap. 21, 144-153, 1998.

307. Harkins JD, Karpiesiuk W, Woods WE, Lehner A, Dirikolu L, Carter W, Boyles J, Tobin T:  Ropivacaine in the horse:  Its pharmacological responses, urinary detection and mass spectral confirmation.  J Vet Pharm Therap, 24:89-98, 2001. [KY Ag. Exp. Sta #98-14-153].

308. Tobin T:  Equine Drug Testing:  How it works, HBPA Medication Booklet, pp. 42-51, 1998 [KY Ag. Exp. Sta. #9814-26].

309. Tobin T:  Dietary, environmental, and endogenous substances in horses. In Medication Reference Guide, National Horsemen’s Benevolent & Protective Association, pp 52-58, 1998.

310. Tobin T, Harkins JD, Carter W, Sams R Stanley S:  An interim report on the Testing Integrity Program seminar “Furosemide in the Horse:  Its Actions, Effects and Regulatory Control”.  The New Orleans Hilton, Riverside, CA, March, 1998.

311. Bosken JM, Lehner AF, Hunsucker A, Harkins JD, Woods WE, Karpiesiuk W, Carter WG, Boyles J, Fisher M, Tobin T: Direct MS-MS identification of isoxsuprine-glucuronide in post-adminstration equine urine.  Can J Vet Res, 64:112-116, 2000. [KY Ag. Exp. Sta #99-14-3]

312. Dirikolu L, Lehner AF, Karpiesiuk W, Harkins JD, Woods WE, Carter WG, Boyles J, Fisher M, Tobin T: Identification of lidocaine and its metabolites in post-administration equine urine by ELISA and MS-MS. J Vet Pharm Therap, 23:215-222, 2000. [KY Ag. Exp. Sta #00-14-91]

313. Tobin T: Equine Forensic Science: An Overview of the Scientific Methods. Booklet Published by Gluck Equine Research Center, Lexington, KY, 1998. [KY Ag. Exp. Sta #98-14-192]

314. Boyles J, Woods WE, Harkins JD, Fisher M, Uboh C, Tobin T: Procedures and quality assurance aspects of the Testing Integrity Program. Submitted to Proceedings of the 52nd Meeting of the Association of Official Racing Chemists, New Orleans, LA, 1999. [KY Ag. Exp. Sta #99-14-27]

315. Harkins JD, et al: Clenbuterol in the horse: A Preliminary analytical report. Submitted to Proceedings of the 52nd Meeting of the Association of Official Racing Chemists, New Orleans, LA, 1999.

316. Lehner AF, Hunsucker A, Bosken JM, Harkins JD, Woods WE, Karpiesiuk W, Almeida P, Dirikolu L, Carter WG, Boyles J, Holtz C, Fisher M, Tobin T: Further characterization of equine isoxsuprine metabolites by electrospray ionization tandem mass spectrometry.  Manuscript in preparation, 2003.

317. Carregaro AB, Woods WE, Queiroz-Neto A, Tobin T: Comparison of the quantification of caffeine in human plasma by gas chromatography and ELISA.  Braz J Med Biol Res, 34:821-824, 2001. [KY Ag Exp Sta #01-14-116]

318. Harkins JD, Robinson NE, Woods WE, Lehner AF, Smith MD, Gates RS, Fisher M, Tobin T: Intratracheal clenbuterol in the horse: Its pharmacological efficacy and analytical detection.  J Vet Pharmacol Therap, 23:251-260, 2000. [KY Ag. Exp. Sta #99-14-167]

319. Lehner AF, Jacobs J, Almeida P, Harkins JD, Karpiesiuk W, Woods WE, Carter W, Boyles J, Dirikolu L, Bosken J, Holtz C, Tobin T: Qualitative identification of celecoxib in equine samples. Manuscript in preparation, 2003.

320. Lehner AF, Almeida P, Jacobs J, Harkins JD, Karpiesiuk W, Woods WE, Dirikolu L, Bosken JM, Carter WG, Boyles J, Holtz C, Heller T, Nattrass C, Fisher M, Tobin T: Remifentanil in the horse: Identification and detection of its major urinary metabolite. J Analytical Toxicol, 24:309-315, 2000. [KY Ag. Exp. Sta #99-07-145]

321. Ramsey EC, Carter W, Geiser D, Tobin T: Serum concentratins and effects of detomidine delivered orally to horses in three different mediums. Vet Anaesthesia and Analgesia, 29:219-222, 2002. [KY Ag Exp Sta #02-14-018]

322. Harkins JD, Woods WE, Lehner AF, Karpiesiuk W, Hughes C, Gates RS, Fisher M, Tobin T: Pyrilamine in the horse: II. Detection and pharmacokinetics of pyrilamine and its major urinary metabolite. Manuscript in preparation, 2001.

323. Xie H, Ott EA, Harkins JD, Tobin T, Colahan PT: Influence of electro-acupuncture on pain threshold in horses and its mode of action. Submitted to J Am Vet Med Assoc, 1999. [KY Ag. Exp. Sta # 99-14-170]

324. Harkins JD, Woods WE, Lehner AF, Fisher M, Tobin T: Clenbuterol in the horse: Urinary concentrations determined by ELISA and GC/MS after clinical doses. J Vet Pharmacol Therap, 24:7-14, 2001. [KY Ag. Exp. Sta #00-14-49]

325. Harkins, JD, Karpiesiuk W, Woods WE, Lehner A, Rees WA, Dirikolu L, Bass S, Carter WG, Boyles J, Tobin T: Ropivacaine in the horse: its pharmacological responses, urinary detection and mass spectral confirmation. J Vet Pharmacol Therap, 24:89-98, 2001.

326. Lehner AF, Harkins JD, Karpiesiuk W, Woods WE, Robinson NE, Dirikolu L, Fisher M, Tobin T: Clenbuterol in the horse: Confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration. J Analyt Toxicol, 25:280-287, 2001. [KY Ag. Exp. Sta #00-14-122]

327. Woods WE, Harkins JD, Lehner AF, Dirikolu L, Karpiesiuk W, Boyles J, Carter WG, Fisher M, Heller T, Tobin T: Detection and disposition of pyrilamine and its metabolite O-desmethylpyrilamine in equine blood and urine: A preliminary report. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp472-477. [KY Ag. Exp. Sta # 00-14-85]

328. Dirikolu L, Lehner AF, Jacobs J, Woods WE, Karpiesiuk W, Harkins JD, Carter WG, Boyles J, Hughes C, Bosken JM, Holtz C, Nattrass C, Fisher M, Tobin T: Celecoxib in the horse: Its recovery, mass spectrometric identification, disposition and major urinary metabolites. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp162-170. [KY Ag. Exp. Sta #00-14-101]

329. Carter WG, Walters K, Chamblin T, Tobin T: A review of Association of Racing Commissioners International class 1, 2 and 3 medication violations and penalties for 1995-1999 in North America. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp303-309.

330. Holtz C, Drinnon R, Gates R, Hughes CG, Woods WE, Sweet A, Dirikolu L, Bosken JM,  Harkins JD, Lehner AF, Carter WG, Karpiesiuk W, Boyles J, Fisher MG, Tobin T: The postural signature device: A non-invasive tool for identifying medication thresholds. A preliminary report. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp46-52. [KY Ag. Exp. Sta #00-14-110]

331. Lehner AF, Almeida P, Harkins JD, Karpiesiuk W, Woods WE, Dirikolu L, Bosken JM, Carter WG, Boyles J, Holtz C, Heller T, Nattrass C, Fisher M, Tobin T: Identification and detection of the major equine urinary metabolite of remifentanil. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp465-471. [KY Ag. Exp. Sta #00-14-104]

332. Lehner AF, Woods WE, Karpiesiuk W, Harkins JD, Fisher M, Tobin T: A highly sensitive detection method for clenbuterol in equine serum. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp420-426. [KY Ag. Exp. Sta #00-14-103]

333. Lehner AF, Hughes C, Woods WE, Karpiesiuk W, Harkins JD, Dirikolu L, Holtz C, Bosken JM, Carter WG, Boyles J, Booze R, Mactutus C, Fisher M, Tobin T: A liquid chromatographic-electrospray tandem MS/MS method for quantitation of equine cocaine metabolites. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp413-419. [KY Ag. Exp. Sta #00-14-105]

334. Patrick S, Heller T, Tobin T, Bratton C, Bass S: Fentanyl group ELISA for the detection of remifentanil and other narcotic analgesics. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp337-340.

335. Karpiesiuk W, Lehner AF, Tobin T: Synthesis and characterization of deuterated clenbuterol and two equine metabolites. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, 427-429. [KY Ag. Exp. Sta #01-14-8]

336. Bosken JM, Tobin T, Mundy GD, Fisher M, Banks RO: Comparison of specific gravity and osmolality in post-race urine of furosemide-treated and control Thoroughbred horses. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp345-349.

337. Dirikolu L, Bentz BG, Lehner AF, Woods WE, Harkins JD, Karpiesiuk W, Carter WG, Boyles J, Granstrom D, Tobin T: New therapeutic approaches to equine protozoal myeloencephalitis: Clinical pharmacology and apparent efficacy of diclazuril, toltrazuril and sulfonotoltrazuril. Submitted to J Vet Pharmacol Therap, 2001. [KY Ag. Exp. Sta #00-14-102]

338. Tobin T, Harkins JD, Fisher M: ‘No-effect limits’: An overview and a pharmacological approach. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp36-42. [KY Ag. Exp. Sta #00-14-198]

339. Hale ND, Tobin T, Tai H-H, Harkins JD, Heller T, Schroedter DE, Bratton C, Mayer B: ELISA assay for stanozolol. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp341-344.

340. Harkins JD, Dirikolu L, Lehner AF, Hughes C, Schroedter D, Mayer B, Bratton C, Fisher M, Tobin T: The detection and biotransformation of guanabenz in horses: A preliminary report. Vet Ther, 4(2): 197-209, 2003. [KY Ag. Exp. Sta. #01-14-113]

341. Harkins JD, Lehner AF, Woods WE, Tobin T: Guanabenz in the horse: Clinical effects and its comparison with other a2 agonists. Manuscript in preparation, 2003.

342. Dirikolu L, Lehner AF, Hughes C, Woods WE, Karpiesiuk W, Harkins JD, Boyles J, Granstrom DE, Tobin T: Toltrazuril sulfone in the horse: Its identification, detection and pharmacokinetics. Manuscript in preparation, 2001.

343. Dirikolu L, Lehner AF, Karpiesiuk W, Hughes C, Woods WE, Carter WG, Boyles J, Harkins JD, Tobin T: Detection, quantification, metabolism and behavioral effects of selegiline in the horse. Veterinary Therapeutics, 4(3):257-268, 2003. [KY Ag. Exp. Sta. #01-14-186]

344. Bosken J, Lehner AF, Woods WE, Hughes CG, Harkins JD, Boyles J, Tobin T: A GC/MS method for the determination of isoxsupri­ne in biological fluids of the horse utilizing electron impact ionization. Manuscript submitted to J Anal Tox, 2003.

345. Dirikolu L, Lehner AF, Hughes C, Woods WE, Karpiesiuk W, Harkins JD, Boyles J, Granstrom DE, Tobin T: Sodium salt formulations of diclazuril and toltrazuril sulfone in the horse: Identification, synthesis, detection and pharmacokinetic­s. Manuscript in preparation, 2001.

346. Dirikolu L, Mollett BA, Woods WE, Lehner AF, Karpiesiuk W, Boyles J, Harkins JD, Bratton C, Tobin T: Apparent ELISA detection times for albuterol after administration with the torpex equine inhaler device. Vet Ther 3(3):297-307, 2002. [KY Ag Exp Sta #02-14-30]

347. Lehner AF, Craig AM, Fannin N, Bush L, Tobin T: Fragmentation patterns of selected ergot alkaloids by electrospray ionization tandem quadrupole mass spectrometry. J Mass Spec, 39(11):1275-862003. [KY Ag Exp Sta #02-14-60]

348. Dirikolu L, Mollett BA, Woods WE, Bratton C, Lehner AF, Karpiesiuk W, Hughes C, Boyles J, Harkins JD, Troppmann A, Tobin T: ELISA “detection times” of albuterol after Torpex™ administration: a preliminary report. In press, Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002.

349. Hughes C, Lehner AF, Crutchfield J, Woods WE, Harkins JD, Karpiesiuk W, Dirikolu L, Sebastian M, Troppmann A, Boyles J, Bosken J, Harrison L, Tobin T: Analytical detection and “normal” population data of cyanide and thiocyanate in equine blood and serum. In press, Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002. [KY Ag Exp Sta #02-14-168]

350. Harkins JD, Tobin T: Pharmacodynamics of guanabenz and related α2 agonists. In press, Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002. [Abstract only]

351. Lehner AF, Hughes C, Woods WE, Harkins JD, Karpiesiuk W, Dirikolu L, Bosken J, Boyles J, Troppmann A, Fisher M, Tobin T: Proposed methodology for the detection of Oxyglobin® in equine plasma. In press, Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002. [KY Ag Exp Sta #02-14-169]

352. Karpiesiuk W, Lehner AF, Dirikolu L, Fisher M, Tobin T: Synthesis and characterization of deuterated standard of furosemide (Salix®). In press, Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002. [KY Ag Exp Sta #02-14-181]

353. Dirikolu L, Lehner AF, Hughes C, Karpiesiuk W, Camargo FC, Harkins JD, Woods WE, Bosken J, Boyles J, Troppmann A, Fisher M, Tobin T: Detection, quantification and pharmacokinetics of furosemide in horses: a preliminary report. In press, Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002. [Ky Ag Exp Sta #03-14-070]

354. Casey PJ, Champion ZJ, Mansell KB, Tobin T: Stallion influence on reproductive loss during Mare Reproductive Loss Syndrome (MRLS) in Lexington, Kentucky 2001. Abstract submitted to Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002.

355. Casey PJ, Korolev AB, Baker IDC, Champion ZJ, Tobin T: The effect of intermittent hypoxic training (IHT) on haematological values, aerobic capacity and performance in racing thoroughbreds. Abstract submitted to Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002.

356. Lehner AF, Meek J, True J, Harkins JD, Karpiesiuk W, Hughes CG, Dirikolu L, Woods WE, Bosken J, Boyles J, Troppmann A, Fannin N, Bush L, Craig AM, Tobin T: Ergot alkaloids screened by HPLC-electrospray[+] tandem quadrupole mass spectrometry.  Manuscript accepted by J Anal Tox, 2002. [KY Ag Exp Sta# 02-14-61]       

357. Hughes CG, Sebastian M, Crutchfield J, Dirikolu L, Harkins JD, Boyles J, Troppmann A, McDowell K, Harrison L, Tobin T: A simple, rapid and highly sensitive spectrophotometric method for determination of cyanide in equine biological samples. Toxicology Mechanisms and Methods 13:129-138, 2003. [KY Ag Exp Sta# 02-14-85]

358. Dirikolu L, Sebastian M, Hughes CG, Crutchfield J, Harkins JD, Boyles J, Troppmann A, McDowell K, Harrison L, Tobin T: The toxicokinetics of cyanide and mandelonitrile in the horse and their relevance to the Mare Reproductive Loss Syndrome. Toxicology Mechanisms and Methods, 13:199-211, 2003. [KY Ag Exp Sta# 02-14-86]

359. Tobin T, McDowell K, Hughes CG, Lehner AF, Crutchfield J, Harkins JD, Dirikolu L, Sebastian M, Harrison L, Williams N, Smith R, Webb B, Newman K, Allman R, Dwyer R, Powell D: The Kentucky 2001 Mare Reproductive Loss Syndrome: overview and preliminary toxicological approaches. Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002. p. 261.

360. Camargo F, Dirikolu L, Sebastian M, Hughes C, Crutchfield J, Harkins JD, Boyles J, Troppmann A, McDowell K, Harrison L, Tobin T: The pharmacokinetics of cyanide and mandelonitrile in the horse and their relevance to the Mare Reproductive Loss Syndrome. In press, Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002. [KY Ag Exp Sta #03-14-071]

361. Queiroz-Neto A, Zamur G, Lacerda-Neto C, Tobin T: Determination of the Highest No-effect Dose (HNED) and of the elimination pattern for cocaine in horses. J Appl Toxicol 22:117-121, 2002. [KY Ag Exp Sta #02-14-156]

362. Powell DG, Troppmann A, and Tobin T (eds): Proceedings of the First Workshop on Mare Reproductive Loss Syndrome. Lexington, KY, 2002. Published 2003.

363. Mayer BA, Tobin T, Tai HH, Harkins JD, Carbajal J, Scherer C, Hawkins T, Bratton C, Schroedter DE: Detection of selegiline and selegiline metabolites in an ELISA assay for amphetamine. Manuscript submitted to Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002.

364. Mayer BA, Tobin T, Tai HH, Harkins JD, Hawkins T, Bratton C, Schroedter DE: ELISA assay for ketamine. Manuscript submitted to Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002.

365. Mayer BA, Tobin T, Tai HH, Harkins JD, Hale ND, Bratton C, Schroedter DE: ELISA assay for guanabenz. Manuscript submitted to Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002.

366. Mayer BA, Tobin T, Tai HH, Harkins JD, Hale ND, Bratton C, Scherer C, Schroedter DE: ELISA assay for apomorphine. Manuscript submitted to Proc 14th Int’l Conf Racing Ana­lysts Vets, Orlando, FL, 2002.

367. Harkins JD, Dirikolu L, Sebastian M, Hughes C, Crutchfield J, Troppmann A, Boyles J, Webb B, McDowell K, Long W, Henning J, Harrison L, Fitzgerald T, Tobin T: Cherry trees, plant cyanogens, caterpillars and Mare Reproductive Loss Syndrome: Toxicological evaluation of a working hypothesis. In Powell DG, Troppman A, Tobin T (eds), Proc First Workshop on Mare Reproductive Loss Syndrome, Lexington, KY, 2002, pp68-74. [KY Ag Exp Sta # 02-14-167]

368. Dirikolu L, Lehner AF, Hughes CG, Karpiesiuk W, Camargo F, Harkins JD, Woods WE, Bosken JM, Boyles J, Troppmann A, Fisher M, Tobin T: The detection, quantification and pharmacokinetics of furosemide and its effects on urinary specific gravity following intravenous administration to horses. Manuscript in press, Veterinary Therapeutics, 2003. [KY Ag. Exp. Sta. #03-14-104]

369. Champion ZJ, Breier BH, Ewen WE, Tobin T, Casey PJ: Blood plasma concentrations of insulin-like growth factor-1 (IGF-1) in resting standardbred horses. The Vet J 163:45-50, 2002.

370. Sebastian M, Williams D, Harrison L, Donahue J, Seahorn T, Slovis N, Richter D, Fuller T, Trail C, Douglas R, Tobin T: Experimentally Induced Mare Reproductive Loss Syndrome Late Fetal Losses with Eastern Tent Caterpillars. In Powell DG, Troppman A, Tobin T (eds), Proc First Workshop on Mare Reproductive Loss Syndrome, Lexington, KY, 2002, pp80-81.

371. Sebastian M, Harkins JD, Jackson C, Fuller T, Trail C, Richter D, Harrison L, and Tobin T: A laboratory animal model of Mare Reproductive Loss Syndrome: preliminary evaluation of a mouse model. In Powell DG, Troppman A, Tobin T (eds), Proc First Workshop on Mare Reproductive Loss Syndrome, Lexington, KY, 2002, pp51-53.

372. Bosken JM, Tobin T, Mundy G, Fisher M, Gantz MG, Banks RO: Effect of furosemide on urine specific gravity and osmolality in Thoroughbred racehorses. Veterinary Therapeutics, 4(3):292-298, 2003. [Ky Ag Exp Sta # 02-14-180]

373. Lehner AF, Hughes CG, Karpiesiuk W, Harkins JD, Dirikolu L, Bosken J, Camargo F, Boyles J, Troppmann A, Woods WE, Tobin T: Development of a method for the detection and confirmation of the α2-agonist amitraz and its metabolites in horse urine. Manuscript accepted by J Anal Tox, 2003.

374. Tobin T: Septic Penetrating Setae/Septic Emboli/Septic Penetrating Setal Emboli (SPS/SE/SPSE): A hypothesis to explain the pathogenesis of the Mare Reproductive Loss Syndrome. Copyright registered at Library of Congress, June 17, 2003, #TXU1111484.

375. Lehner AF, Hughes CG, Harkins JD, Nickerson C, Mollett B, Dirikolu L, Bosken JM, Camargo F, Boyles J, Troppmann A, Karpiesiuk W, Woods WE, Tobin T: Detection and confirmation of ractopamine and its metabolites in horse urine after Paylean(R) administration. Manuscript accepted by J Anal Tox, 2003. [KY Ag Exp Sta # 03-14-041]

376. Tobin T: The past and future of equine drug testing and medication regulation. Proc 24th Bain-Fallon Memorial Lectures, Gold Coast, Australia, 2002, pp.8-12.

377. Tobin T: Factors affecting “detection times” and “withdrawal times” for NSAIDs. Proc 24th Bain-Fallon Memorial Lectures, Gold Coast, Australia, 2002, pp.13-17.

378. Tobin T: Pre-purchase and drug testing of horses: a review. Proc 24th Bain-Fallon Memorial Lectures, Gold Coast, Australia, 2002, pp. 18-22.

379. Tobin T: The Mare Reproductive Loss Syndrome: an ongoing toxicological/other investigation. Submitted to Proc 24th Bain-Fallon Memorial Lectures, Gold Coast, Australia, 2002.

380. Stirling K, Bellocq R, and Tobin T: National Horsemen’s Benevolent and Protective Association, Inc. Proposed National Policy on Drug Testing and Therapeutic Medication. J Eq Vet Sci 23(1): 4-5, 18-40, 2003. [Ky Ag Exp Sta# 03-14-072]

381. Sebastian MM, Gantz M, Tobin T, Harkins JD, Bosken JM, Hughes CG, Harrison LR, Bernard WV, Richter D and Fitzgerald TD: Eastern tent caterpillars and the Mare Reproductive Loss Syndrome: Clinical, epidemiological and mechanistic implications of a toxicokinetic/statistical analysis. Manuscript submitted to Veterinary Therapeutics, 2003.

382. Tobin T: Summary, Session 5: MRLS and Associated Syndromes: Toxicological Hypotheses. In Powell DG, Troppman A, Tobin T (eds), Proc First Workshop on Mare Reproductive Loss Syndrome, Lexington, KY, 2002, p75.

383. Harkins JD, Dirikolu L, Lehner AF, Hughes CG, Woods WE, Schroedter D, Mayer B, Bratton C, Fisher MV, Tobin T: Short Communication: A rapid and sensitive Enzyme Linked ImmunoSorbent Assay (ELISA) test for guanabenz in the horse. Manuscript in preparation, 2003.

384. Tobin T: Test of time. The Blood Horse, November 17, 1990, pp. 6188-6190.

385. Carter WG, Troppmann A, Tobin T, Franklin B: An overview of the effective world rules on therapeutic medications. Booklet published by Gluck Equine Research Center.

386. Mundy GD, Stanley SD, Tobin T: Analysis of prohibited substances in Kentucky with emphasis on strategies for practitio­ners to avoid problems. Proc 41st Convent Am Assoc Equine Pract, Lexington, KY, 1995, pp160-162.

387. Tobin T, Harkins JD, Woods WE, Queiroz-Neto A, Stanley SD, Mundy GD: Over­view of di­etary, envi­ron­men­tal, and endoge­nous sub­stanc­es of regulato­ry concern in racing horses. Proc 41st Convent Am Assoc Equine Pract, Lexington, KY, 1995, pp156-159.

388. Tobin T: Trace Level Benzoylecgonine Identifications in Post-Race Urines: Probable Sources and the Regulatory Significance of Such Identifications, HBPA Booklet pub­lished by Gluck Equine Re­search Center, Lexington, KY, 2000.  Also: Appendix II: Currently in place “limits” or “cutoffs” or thresholds for cocaine/benzoylecgonine.

389. Rees WA, Harkins JD, Lu M, Holland RE, Lehner A, Tobin T, Chambers TM: Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2. Am J Vet Res, 60:888-894, 1999. [KY Ag Exp Sta #96-14-131].

390. Harkins JD, Queiroz-Neto A, Mundy GD, West D, Tobin T: Development and characterization of an equine behavior chamber and the effects of amitraz and detomidine on spontaneous locomotor activity. J Vet Pharmacol Therap, 20:396-401, 1997.

391. Harkins JD, Lehner A, Karpiesiuk W, Woods WE, Dirikolu L, Boyles J, Carter WG, Tobin T: Bupivacaine in the horse: Relationship of local anaesthetic responses and urinary concentrations of 3-hydroxybupivacaine. J Vet Pharmacol Therap, 22:181-195, 1999. [KY Ag Exp Sta #98-14-166]

392. Dirikolu L, Lehner AF, Karpiesiuk W, Hughes C, Woods WE, Bosken J, Carter WG, Boyles J, Harkins JD, Tobin T: Detection of selegiline and its major urinary metabolite, N-desmethylselegilin­e, in equine urine: A preliminary report. Submitted to Proceedings of the 54th Meeting of the Association of Official Racing Chemists, Lexington, KY, 2001.[KY Ag Exp Sta #01-14-186]

393. Tobin T, Harkins JD, Lehner AF, Woods WE, Karpiesiuk W, Dirikolu L, Carter W, Boyles J, Sams RA: An overview of analyti­cal/pharmacological relationships and the need for limita­tions on the sensitivity of testing for certain agents. Proc 12th Int’l Conf Racing Ana­lysts Vets, Vancouver, Canada, 1998, pp210-216. [KY Ag Exp Sta #98-14-50]

394. Lehner AF, Hughes CG, Karpiesiuk W, Harkins JD, Bosken JM, Camargo F, Boyles J, Troppmann A, Woods WE and Tobin T: (2004) Metabolism of the α2-agonist amitraz in horses and confirmation of its administration, Proc 15th Intl Conf Racing Analysts Vets, pp. 155-160 [KY Ag Exp Sta #04-14-010].

395. Lehner AF, Hughes CG, Harkins JD, Bosken JM, Camargo F, Boyles J, Troppmann A, Karpiesiuk W, Woods WE and Tobin T(2004) Metabolism of the beta-adrenergic agonist ractopamine in horses and confirmation of its administration with GC/MS. 15th Intl Conf Racing Analysts Vets, pp.93-98 [KY Ag Exp Sta #04-14-008]

396. Hughes CG, Lehner AF, Harkins JD and Tobin T: Preliminary report on the confirmation and quantitative determination of salmeterol in equine urine. Proc 15th Intl Conf Racing Analysts Vets, 2004. p. 406-411[KY Ag Exp Sta #04-14-009]

397. Gantz MG, Harkins JD, Sebastian M, Bosken J, Hughes CG, Harrison L, Bernard WV, Richter D, Fitzgerald TD and Tobin T: A toxicokinetic/Accelerated Failure Time Analysis of the Mare Reproductive Loss Syndrome (MRLS). Proc 15th Intl Conf Racing Analysts Vets, 2004. p212-217 [KY Ag Exp Sta #04-14-020]

398. Tobin T: Septic Penetrating Setae/Bacteria/Bacterial Emboli/Septic Penetrating Setal Emboli (SPS/B/BE/SPSE): A hypothesis to explain the pathogenesis of Mare Reproductive Loss Syndrome. 15th Intl Conf Racing Analysts Vets, p. 418-422 , 2004.

399. Karpiesiuk W, Lehner AF and Tobin T: Synthesis and certification of salmeterol and salmeterol-d12 standards. Proc 15th Intl Conf Racing Analysts Vets, 2004. p405

400. Tobin T, Harkins JD, VanMeter PW, Fuller TA: The Mare Reproductive Loss Syndrome II: Clinical evaluation of the syndrome and a proposed mechanism: septic penetrating setae. Int J Applied Res in Vet Med, 2004.

401. Lehner AF, Hughes CG, Harkins JD, Karpiesiuk W, Camargo F, Boyles J, Woods WE and Tobin T: Detection and identification of dizocilpine and its major urinary metabolites in the horse: a preliminary report. Chromatographia 59:S95-S103, 2004. [KY Ag Exp Sta #04-14-003]

402. Lehner AF, Hughes CG, Karpiesiuk W, Camargo FC, Harkins JD, Woods WE, Bosken J, Boyles J, Troppmann A and Tobin T: Determination of salmeterol in equine urine and serum. Chromatographia 59:S79-S84, 2004. [KY Ag Exp Sta# 04-14-011]

403. Hall NC, Yang J-M, Stanley SD, Mundy GD, Kryscio R, Tai HH, Rees WA Blake JW, Woods WE and Tobin T: Number of negative tests required to exclude specified levels of agent abuse in equine forensic chemistry. Manuscript in progress, 2004.

404. Karpiesiuk W, Lehner AF, Hughes CG, and Tobin T (2004): Preparation and Chromatographic Characterization of tetrahydrogestrinone (THG), a New “designer” Anabolic Steroid. Chromatographia, 60, 359-363. [KY Ag Exp Sta #04-14-052

405. Dirikolu L, Karpiesiuk W, Lehner AF, Hughes, C., Woods WE, Harkins JD, Boyles J, Atkinson A, Granstrom D, and Tobin T. (2004) New Therapeutic Approaches for Equine Protozoal Myelitis: Synthesis and Pharmacokinetics of Diclazuril Sodium Salt in the Horse: Proceedings of the 15th International Conference of Racing Analysts and Veterinarians, Dubai, pp 135-140

406. Karpiesiuk W, Lehner AF, Hughes CG, Guan F, Uboh C, Soma L, Bratton C, Kellerman L and Tobin T: (2004) Preparation and analysis of tetrahydrogestrinone (THG), a recently reported “designer” anabolic steroid. Proc 15th Intl Conf Racing Analysts Vets,.p518-522

407. Camargo FC, Lehner AF, Karpiesiuk W, Stirling K., Kavanagh PV, Brennan N, Dowling M., and Tobin T. (2005) Review of Environmental Morphine Identifications: World wide occurrences and Responses of Authorities.  AAEP Proc. vol. 61 p58-64

408. Guan F, Uboh CE, Soma LR, Luo Y, Rudy J, and Tobin T., (2005) Detection, quantification and confirmation of anabolic steroids in equine plasma by liquid chromatography and tandem mass spectrometry. Journal of Chromatography B 829 56–68.

409. Tobin T., Camargo FC, Lehner AF, and Karpiesiuk W. (2005)  Drugs Medications and Performance Altering Substances: Their Performance Effects, Detection and Regulation: From 1800 to Keenland Oct 12th 2005

410. Camargo FC, Robinson NE, Berney C, Eberhart S, Baker S, DeTolve P, Derksen FJ, Harkins JD, Lehner AF, and Tobin T. 2006. Intravenous and intratracheal administration of trimetoquinol, a fast-acting short-lived bronchodilator in horses with 'heaves'. Equine Vet J. 38(6):563-9

411. Tobin T, Hughes C, Lehner AF, Camargo FC: (2006) Synthesis of deuterated analytical standards:  Ketoprofen-d3 and Flunixin-d3. Proceedings of the 16th International Conference of Racing Analysts and Veterinarians, Tokyo, Japan, pp214-217

412. Camargo FC, Hughes C, Lehner AF and Tobin T. (2006) Trace Level Benzoylecgonine Identifications in Post-Race Urines: Probable Sources and the Regulatory Significance of Such Identifications. AAEP Proc. Vol. 52 p331-336

413. Camargo FC, Robinson NE, Berney C, Eberhart S, Baker S, Detolve P, Derksen FJ, Lehner AF, Hughes C, Tobin T. (2007) Trimetoquinol: bronchodilator effects in horses with heaves following aerosolised and oral administration. Equine Vet J. 39(3):215-20

414. Budharaja A., Camargo FC,  Hughes C, Lehner AF,  Stirling K., Brennan N, Dowling M., and Tobin T (2007) Caffeine and Theobromine Identifications in Post race Urines: Threshold Levels and Regulatory Significance of Such Identifications. AAEP Proc. Vol. 53 p87-92.

415. Lehner AF, Stewart J, Dafalla A, Ely KJ, Connerly AL, Jones CN, ElkHoly H, Thompson K, Tobin T, Dirikolu L. (2007) Gabapentin in horses: validation of an analytical method for gabapentin quantitation. J Anal Toxicol. 31(9):555-65

416. Camargo FC, Robinson NE, Dirikolu L, Berney C, Eberhart S, Derksen FJ, Lehner AF, May J, Hughes C,Tobin T., (2008) Plasma and urinary concentrations of trimetoquinol by LC-MS-MS following intravenous and intra-tracheal administration to horses with heaves. J Vet Pharmacol Ther 31(6):501-10

417. Dirikolu L, Dafalla A, Ely KJ, Connerly AL, Jones CN, ElkHoly H, Lehner AF, Thompson K, and Tobin T.(2008) Pharmacokinetics of gabapentin in horses. J Vet Pharmacol Ther. 31(2):175-7.

418. Spencer WA, Camargo FC, Karpiesiuk  W., Stirling K., Casey PJ, and Tobin T. (2008). Review of the Current Status of Thresholds/Withdrawal Time Guidelines for Therapeutic Medications in Performance Horses. AAEP proc. Vol.54 p29-37

419. Dirikolu L., Woods WE, Boyles J.,  Lehner A F,  Harkins JD,  Fisher M, Schaeffer DJ and  Tobin T (2008)  Nonsteroidal anti-inflammatory agents and musculoskeletal injuries inThoroughbred racehorses in Kentucky J. vet. Pharmacol. Therap. doi: 10.1111/j.1365-2885.2008.01038.x

420. Dirikolu L, Lehner AF, Hughes C, Karpiesiuk, W  and Tobin T: (2008) New Therapeutic Approaches to Equine Protozoal Myelitis: Pharmacokinetics of Toltrazuril Sulfone Sodium Salts in the Horse AAEP Proc. Vol.54 p191

421. Lehner AF, Fitzgerald BP, Hughes CG, Tobin T, Camargo FC., May J, Dirikolu L, Christiansen DL, and Ryan PL. (2008) Serum concentrations of ergovaline/ergot alkaloids in late-term pregnant mares grazing entophyte infected tall fescue pastures: A preliminary  report.  Theriogenology 70 (2008) p583

422. Dirikolu L, Lehner AF, Harkins JD, Woods WE, Karpiesiuk W, Gates RS, Fisher M, Tobin T: (2009) Pyrilamine in the horse: Detection and pharmacokinetics of pyrilamine and its major urinary metabolite “O-desmethylpyrilamine”. J Vet Pharmacol Ther. 2009 Feb;32(1):66-78

423. Lehner AF, Petzinger E, Stewart J, Lang DG, Johnson MB, Harrison L, Seanor JW, Tobin T. (2009) ESI+MS/MS confirmation of canine ivermectin toxicity J Mass Spectrom.44(1):1119.

424. Dirikolu L, Karpiesiuk W, Lehner AF, Hughes, C, Granstrom D and  Tobin, T (2009) Effect of Dimethylsulphoxide On Oral bioavailability Of a Triazine Based Antiprotozoalagent Toltrazuril Sulfone In The Horse. Proceedings of the 17th International Conference of Racing Analysts and Veterinarians, Antalya, Turkey. pp.315-320

425. Dirikolu L, Woods WE, Boyles J, Lehner AF, Harkins JD, Fisher M, Schaeffer DJ and Tobin T.(2008) Nonsteroidal Anti-Inflammatory Agents And Musculoskeletal Injuries In Thoroughbred Racehorses In Kentucky. Proceedings of the 17th International Conference of Racing Analysts and Veterinarians, Antalya, Turkey. pp 329-333

426. Dirikolu L, Karpiesiuk W, Lehner AF, Hughes, C, Granstrom D and  Tobin, T (2009) Synthesis and Detection Of Toltrazuril Sulfone and Its Pharmacokinetics In Horses Following Administration In Dimethylsulfoxide. J Vet Pharmacol Ther. 2009 Aug; 32(4):368-78

427. Dhanjal JK, Wilson DV, Robinson NE and Tobin T (2009) Intravenous Tramadol: Effects, Nociceptive Properties, and Pharmacokinetics in Horses. Veterinary Anaesthesia and Analgesia 36, 581-590.

428. Dhanjal JK, Wilson DV, Hughes CG, Karpiesiuk W, Spencer W, Tharappel J, Dirikolu L, Lehner A and Robinson NE (2008) Tramadol in the Horse: A Preliminary Report on its Detection, Pharmacokinetics and Pharmacodynamics Responses. Proceedings of the 17th International Conference of Racing Analysts and Veterinarians, Antalya, Turkey, pp 106-115.

429. Dirikolu L, Karpiesiuk, W, Lehner F and Tobin T., Toltrazuril Sulfone Sodium Salt: Synthesis, Analytical Detection, and Pharmacokinetics in the Horse J Vet Pharmacol Ther 2011 Kentucky Ag Expt Station Number 11-14-046

430. Thomas Tobin and Kent H. Stirling (2009) Equine Drug Testing & Therapeutic Medication Regulation; 2009 Policy of the National Horsemen's Benevolent and Protective Association, Inc. Wind Publications, 600 Overbrook Dr, Nicholasville, KY 40356, USA pp 170

431. Tobin T, Eisenberg, R., Gutierrez, J., Long, S., Li, T., Tharappel, J., Hughes, C., Armstrong, E., Mayer, B., Stanley, E., Lyons, M and Karpiesiuk, W. (2010) Certified Reference Standards and Stable Isotope Internal Standards for Equine Therapeutic Medication Regulation. In press, Proceedings of the 18th International Conference of Racing Analysts and Veterinarians,Queens Town, New Zealand

432. Tobin, T., Gutierrez, J., and Eisenberg, R., (2010) Experiences as an Expert: Educating People While Under Oath, 25 Years since Hong Kong.  In press, Proceedings of the 18th International Conference of Racing Analysts and Veterinarians,QueensTown, New Zealand

433. Rich Harden and Thomas Tobin (2010) “Shipping In” A Risk Factor Associated with Fatal Musculoskeletal Racing Injuries. Submitted for publication, J Eq Vet Sci

434. Tobin, T.,Koval, N. and Harden, R.,(2010)  Fatal Musculoskeletal Injury Rates and Regulatory Thresholds for Phenylbutazone, in final draft

435. Gutierrez J, Eisenberg RL, Koval NJ, Armstrong ER., Tharappel J, Hughes CG, Tobin, T (2010) Pemoline and Tetramisole “Positives” In English Racehorses Following Levamisole Administration.  Irish Vet J 63 (8) 498-500

436. Race for the Prize (2010) Robert Hogan Interviews Thomas Tobin in Irish Veterinary Journal. Irish Vet J 63 (8) 482-484.

437. Julio Gutierrez, Rodney Eisenberg, Gabrielle Herrensmith, Thomas Tobin, Tonglei Li* and  Sihui Long * Conformational Polymorphism in 2-((4-hydroxy-2,6-dimethylphenyl) amino)-5,6-dihydro-4H-1,3-thiazin-3-ium Chloride,  2010, C66, p 593-595, Acta Crystallographica Section C: Crystal Structure Communications. Ky Ag Expt Station Numberr 10-14-123 UK #392. PMID: 21123891 [PubMed]

438. Helieh S. Oz1,2, DVM, MS, PhD, AGAF ; Thomas Tobin3, MVB, MSc, PhD, MRCVS, DABT Efficacy of Diclazuril Protection in a Mouse Model of Fetal Toxoplasmosis, in final draft 2011 UK #395.

439. Gutierrez Julio a, Rodney Eisenbergb, Gabrielle Herrensmitha, Thomas Tobina, Tonglei Lic, Sihui Longc* Solvatomorphism in E)-2-(2,6-dichloro-4-hydroxybenzylidene)hydrazinecarboximidamide, Submitted for publication February 2011, Acta Crystallographica Reference: sq3285  UK# 394, PMID: 21817799  [PubMed]

440.   Lehner Andreas F., Jennifer M. Duringerb, Charles T. Estillc, Thomas Tobind, A. Morrie Craige  ESI-Mass spectrometric and HPLC elucidation of a new ergot alkaloid from perennial ryegrass hay silage associated with bovine reproductive problems, In press, Toxicology Mechanisms and Methods, 2011 KAES Article # 11-14-031 UK # 396.

441. Thomas Tobin Kimberly Brewer, and Kent H. Stirling (2012) World Rules for Equine Drug Testing and Therapeutic Medication Regulation; 2012 Policy of the National Horsemen's Benevolent and Protective Association, Inc. Wind Publications, 600 Overbrook Dr, Nicholasville, KY 40356, USA pp 370  KAES Article # 11-014-096 UK # 397 .

442. Julio Gutierrez, Rod Eisenberg, Elizabeth Marie Ferguson, Charlie Hughes and Thomas Tobin  “Synthesis of myo-inositol trispyrophosphate (ITPP)  for use as an analytical standard” Submitted for publication, 18th international conference of racing analysts and veterinarians, Philadelphia Pennsylvania, September 15-22, 2012

443. Thomas Tobin, Richard H Galley, Kimberly Brewer, Abelardo Morales Briceno and Diana      Villoria Leon:   Furosemide, the Prevention of Epistaxis and Related Considerations: A Preliminary Evaluation: Submitted for publication,  Irish Veterinary Journal, March, 2012.

444. Dr. Keith H. Soring, DVMa,   Dr. Kimberly Brewer DVMb,  A J Kind, BA, FAORCc, Dr. Thomas Tobin, MVB, MSc, PhD, MRCVS, DABTd  FOREIGN SUBSTANCES REPORTED IN IOWA    RACING, 2001 – 2011:  A REVIEW AND ANALYSIS, Submitted for presentation and   publication, American Association of Equine Practitioners Annual Convention, Anaheim CA  December 3rdpubs

445. Kind AJ, Soring K, JD, Brewer K , Eisenberg, R, Hughes CG, Hartmann-Fishbach, P  and Tobin T (2012) Cathinone and Related “Bath Salt” Substances – Detection in Equine Urine and Potential Sources, The 19th International Conference of Racing Analysts and Veterinarians, University of Pennsylvania, Philadelphia, Pennsylvania, September 2012. [UK401, Ag. Experiment Station Number, 12-14-099, published, Dec 2014]
447. Kudrimoti S, Gutierrez J, Eisenberg R, Ferguson EM, Hughes C and Tobin T (2012) Synthesis of 3-Hydroxy-mepivacaine-d3 as an Internal Standard for Equine Medication Regulation, Submitted for publication, The 19th International Conference of Racing Analysts and Veterinarians, University of Pennsylvania, Philadelphia, Pennsylvania, September 2012. [UK 402 Ag. Experiment Station Number, 12-14-101]
449. Tobin, T, Brewer, K and Hughes, C (2012) A Clinician’s Guide to Factors Affecting Withdrawal Times, The Veterinary Journal, 198 (2), 313-321 2013  [UK 403 Ag. Experiment Station Number, 13-14-011]
     
     
450. Tobin, T and Brewer, K (2012)  Furosemide, Epistaxis and the Racing Horse: A review and Analysis: in progress, invited review for the Veterinary Journal [UK404]
     
     
451. Oz, H, and Tobin T, Atovaquone Ameliorates Gastrointestinal Toxoplasmosis complications in A Pregnancy Model: , Med Sci Monit. 2012 Sep;18(9):BR337-45. PMID: 22936182 [UK405] KAES Article # 12-14-084 
       
452. Briceno, AM, Leon, DV, Brewer, K and Tobin, T (2012) A Toxicology and Clinical Study of Post-Race Epistaxis Associated with Exercise Induced Pulmonary Hemorrhage in Thoroughbred Race Horses at the Racecourse Rinconada, Caracas, Venezuela, Vol 1 #7 http://dx.doi.org/10.4172/scientificreports.348  Open Access Scientific Reports UK406]
        
     
453. Dirikolu L, Foreman, JH, Tobin, T (2013) Current Therapeutic Approaches to Equine Protozoal Myeloencephalitis, American Journal of Veterinary Research 242(4):482-491. [UK#407, KAES Article #13-14-008, PMID:23363280]
      
454. Fenger, C, Haines, D, Casey, P, Langemeier, J and Tobin T (2013) Bovine Colostrum supplementation does not influence serum IGF-1 in horses in race training, Submitted for publication, The Veterinary Journal, March 1, 2013. [UK#408, KAES Article #13-14-044]
     
     
455. Fenger, C, Haines, D, Casey P, Langemeier, J and Tobin, T: Bovine Colostrum supplementation decreases the incidence of upper respiratory infection in horses in race training and may improve performance and recovery; Submitted for presentation and publication, Proceedings of the 59th AAEP Annual Convention, Nashville, Tennessee December 7-11, 2013, [UK#408 KAES Article # 13-14-047
     
     
456. Kimberly Brewera, Levent Dirikolub, Charlie G. Hughesc, Thomas Tobinc* Scopolamine in racing horses: trace identifications associated with dietary or environmental exposure”  The Veterinary Journal, Volume 199, Issue 3, March 2014, Pages 324–331.
     
     
457. H. Oz and T. Tobin, "Diclazuril Protects against Maternal Gastrointestinal Syndrome and Congenital Toxoplasmosis, 2014 International Journal of Clinical Medicine, Vol. 5 No. 3, 2014, pp. 93-101. doi: 10.4236/ijcm. 2014.53017.
458. Fenger, CK, Tobin, T, Casey, PJ, Roualdes, E, Langemeier, JL and Haines, DM. 2014: Bovine colostrum supplementation improves earnings, performance and recovery in racing Thoroughbreds.  Journal Comparative Exercise Physiology, Volume 10, Number 4, pages 233-238, UK AG School number  14-14-052
     
     
459. Kimberly Brewera, Theodore F. Shultsb, Thomas Tobinc*, Sucheta Kudrimotic, Rodney L. Eisenbergd, Petra Hartman f, Caroline Wang f, Charlie Hughes c, Jacob Machind, and Pierre Beaumier g A Cluster of Trace-Concentration Methamphetamine Identifications in Racehorses Associated with a Methamphetamine-contaminated Horse Trailer: A Report and Analysis:  Accepted for publication, Canadian Veterinary Journal, October, 2015. Kentucky Agricultural Experiment Station (KAES Publication  # 15-14-057). Equine publication # 424.
     
     
460. Tobin T:  Opiates, enkephalins and racing horses.  Equine Veterinary Science, 2(1):32-33, Jan/Feb 1982.
     
     
461. Morales A, Mendez A, Brewer K, Tobin T. Muerte subita en caballos de alta competencia. Aspectos patologicos y serie de caso clinicos de revision. Revista Equinus, 41, p.48-62, 2015
     
     
462. Morales A, Mendez A, Brewer K, Tobin, T. Muerte subita en caballos pura sangre de carreras, Gaceta Hipica, 149, 3, p.23, 2015
     
     
463. Fenger, C., Tobin, T., Casey, P., Langemeier, J. and Haines, D. Bovine colostrum supplementation does not influence serum insulin-like growth factor-1 in horses in race training. Journal of Equine Veterinary Science, 34(8):1025-1027, August 2014
     
     
464. Da Silva E, Rossini V, Rivero L, Morales A, Mendez A, Brewer K, Tobin T. Deteccion de furosemide y otras substancias en caballos de Carrera [Furosemide and detection of foreign substances in race horses, Archivos Venezolonos de Farmacologia y Terapeuktica, 33:4, p.76-79, 2014
465. Morales A, Mendez-Sanchez A, Armas M, Guarino C, Moya M, Suniaga E, Brewer K, Tobin T. Estudio comparativo del efecto de la combinacion levotiroxina-clenbuterol en ratones Balb/c y ratas Sprague Dawley, Patologia, 53, p.141-150, 2015
     
     
466. Morales Briceno, A., Mendez Sanchez, A., Brewer, K., Tobin, T. Medicasion terapeutica en caballos pura sangre de carreras en Venezuela, Revista Contacto Veterinario, 14:27, p.34, 2014
     
     
467. S. Kudrimoti, R. Eisenberg, G. A. Maylin, Charlie Hughes, and T. Tobin. Synthesis and characterization of 4-hydroxyxylazine and 4-hydroxyxylazine-d6 standards for use in xylazine regulation in competition horses: Presented and in press, September 2014, the 20th International Conference of Racing Analysts and Veterinarians, Sugar Beach, Mauritius, p332-335, KAES 15-14-005.
     
     
468. R. Eisenberg, S. Kudrimoti, C. G. Hughes, G. A. Maylin, and T. Tobin. Dihydromethylprednisone, an isomeric metabolite of methylprednisolone: synthesis of an analytical standard Presented September 2014, 20th International Conference of Racing Analysts and Veterinarians, Sugar Beach, Mauritius, p 270-274, KAES # 15-14-092.
     
     
469. S. Kudrimoti, R. Eisenberg, G. A. Maylin, C.G. Hughes and T. Tobin. 20-Dihydroprednisone: Synthesis of an isomeric equine metabolite of prednisolone for use as an analytical standard; Presented and in press at the 20th International Conference of Racing Analysts and Veterinarians, Sugar Beach, Mauritius, September 2014, p 346-350, KAES# 15-14-006.
     
     
470. K. Brewer, C. R. Harden, C.G. Hughes and T. Tobin. "Shipping-in," a risk factor associated with fatal musculoskeletal racing injuries: Presented and in press, the 20th International Conference of Racing Analysts and Veterinarians, Sugar Beach, Mauritius, September 2014, p 426.
     
     
471. A.M. Bricerio, A.M. Sanchez, R.H. Galley, K. Brewer, C. Hughes, T. Tobin. Increased Incidence of Sudden Death Associated with Exercise Induced Pulmonary Hemorrhage (EIPH) in Horses Racing at Higher Altitude in Venezuela: Presented and Published, the 20th International Conference of Racing Analysts and Veterinarians, Sugar Beach, Mauritius, September 2014, pages 414-421, Equine publication # 420, KAES Publication  # 14-14-096.
     
     
472. Fenger, C. K., Tobin, T., Casey, P. J., Roualdes, E., Langemeier, J. L., and Haines, D.M. Bovine Colostrum Supplementation Improves Earnings, Performance and Recovery in Racing Thoroughbreds. Presented at the 20th International Conference of Racing Analysts and Veterinarians, Sugar Beach, Mauritius, September 2014, Pages.
     
     
473. Fenger, C, Tobin, T, Casey, P, Roualdes, E, Langemeier J, Cowles, R and Haines, D, Enhanced Bovine Colostrum Supplement Shortens the Duration of Respiratory Disease in Thoroughbred Yearlings, Submitted for publication, J. Equine Veterinary Science, January, 2016.  (KAES Publication  # 16-14-005)
     
     
474. A. Queiroz-Neto1, A.B. Carregaro1, G. Zamur1, J.D. Harkins2 , T. Tobin2, M.I. Mataqueiro, S.C. Gonçalves  Effect of amitraz and xylazine on some physiological variables of horses Arq. Bras. Med. Vet. Zootec. vol.52 n.1 Belo Horizonte Feb. 2000, http://dx.doi.org/ 10.1590/S0102-09352000000100008 
     
     
475. Everett Macombera, Glenys Nobleb, Kimberly Brewerc, Jake Machind, Abelardo Morales Briceñoe, Mary Ann O’Connellf, Kent Stirlingg, Rodney Eisenbergh,  S Kudrimotid, Clara Fengeri, and Thomas Tobind* Regulatory Thresholds for Xylazine; A Case Report and Review Based on Recent Regulatory Events:  Submitted for publication, Canadian Veterinary Journal.
     
     
476. Tobin, T THREE SEQUENCES OF LOW CONCENTRATION URINARY IDENTIFICATIONS OF CATHINONE IN IOWA, RIO DE JANEIRO AND SAO PAULO WITH NO APPARENT FORENSIC SIGNIFICANCE; A PRELIMINARY ANALYSIS. Report requested by and prepared for Dr. Goran Akerstrom,  Director, Fédération Equestre Internationale, Veterinary Department, King Hussein 1 Building, Chemin de la Joliette, 1006 Lausanne Switzerland, Submitted, April 4th, 2016.
     
     
477. Kimberly Brewer1, Jake Machin5  Theodore F. Shults2, Gregory A. Hood3, Charlie G. Hughes 5, Clara Fenger4 and Thomas Tobin 5 Tramadol: A Human Therapeutic Medication and an Environmental Substance Occasionally Identified in Equine Drug Testing Final draft publication, British Veterinary Journal.
     
     
478.  Nicola Pusterla, DVM, PhD,a,* Thomas Tobin, MVB, PhDb   “Update on EPM Therapeutics”; In press, “Veterinary Clinics of North America: Equine Practice”  Equine Pharmacology, Vet Clin Equine 33 (2017) 87-97.
     
     
479. Tobin, T, Codreanu, M, Therapeutics: 2006 “From Therapeutic Use to Abuse in Horses- Overview on Performance Altering Substances and their Detection in Racehorses" Romania, Ministry of Education and Research, University of Agronomy, All Sciences and Veterinary Medicine, Bucharest, Faculty of Veterinary medicine; Scientific Works, Veterinary Medicine, C Series XLIX 2006 Bucharest, pages 195-204.
     
     
480. R . Eisenberg, S. Kudrimoti, C. G. Hughes, G. A. Maylin, and T. Tobin. 2014 Synthesis purification and chemical characterization of 20 Dihydromethylprednisone, an isomeric metabolite of methylprednisolone in the horse for use as an analytical standard: Drug Testing and Analysis, 6(3) :303-307.
     
     
481. Brewer K, Maylin GA, Fenger CK, Tobin T. 2016. Cobalt Use and Regulation in Horseracing: A Review. Comparative Exercise Physiology. 12(1):1-10.
     
     
482. Kevin Kersh, DVM, DACVS; Scott R. McClure, DVM, PhD, DACVS, DACVSMR; Jake Machin, MS; Levent Dirikolu, PhD; Brad Brown, DVM; Clara Fenger, DVM, PhD, DACVIM; George Maylin, DVM, PhD; Edward Roualdes, PhD; Thomas Tobin, MRCVS, PhD, DABT Determining viable withdrawal times for dexamethasone in horses in a racing environment, where self-contamination is likely:  Clinical Guidelines for application in a regulatory environment.  Presented and accepted for publication at the 21st International Conference of Racing Analysts and Veterinarians, Montevideo, Uruguay, October 15-22nd, 2016.
     
     
483. Abelardo Morales Briceño1,, Aniceto Mendez Sanchez1, Kimberly Brewer2,Thomas Tobin3 FOREIGN SUBSTANCES IDENTIFIED POST RACE IN THOROUGHBREDS AT LA RINCONADA RACETRACK, CARACAS VENEZUELA, A CLINICAL PATHOLOGICAL AND TOXICOLOGICAL STUDY. Presented and accepted for publication at the 21st International Conference of Racing Analysts and Veterinarians, Montevideo, Uruguay, October 15-22nd, 2016.
     
     
484. Abelardo Morales Briceño1,2, Antonio Lamprea Garrido2, Alicia Garcia Hermoso2, Aniceto Mendez Sanchez1, Kimberly Brewer3,Thomas Tobin5 EPISTAXIS IN UNMEDICATED EQUINE DURING INTENSE EXERCISE IN ALMONTE-HUELVA-SPAIN. A PRELIMINARY REPORT: Presented and accepted for publication at the 21st International Conference of Racing Analysts and Veterinarians, Montevideo, Uruguay, October 15-22nd, 2016.
     
     
485. Thomas Tobin* 1 Jake Machin1,  Sucheta Kudrimoti1 and Rodney Eisenberg2  Synthesis and Certification of a Deuterated Internal Standard for Xylazine: Presented and accepted for publication at the 21st International Conference of Racing Analysts and Veterinarians, Montevideo, Uruguay, October 15-22nd, 2016.

ABSTRACTS

• Tobin T, Sen AK:  Ouabain inhibition and ligand affinities of the (Na++K+)-ATPase.  Proc Fed Biol Soc 11, 93, 1968.
• Tobin T, Sen AK:  Ligand sensitivity and reversibility of ouabain binding to guinea pig (Na++K+)-ATPase.  Proc Fourth Int’l Cong Pharmacology (Basel, 1969), 199, 1968.
• Tobin T, Brody TM:  Alkali metal cation stabilization of [3H]-ouabain binding to (Na++K+)-ATPase.  Fed Proc 30, 780, 1971.
• Tobin T, Akera T, Brody TM:  The rates of dissociation of enzyme ouabain and apparent Ki values in (Na++K+)-ATPase from different species.  Pharmacologist 13, 308, 1971.
• Akera T, Tobin T, Brody TM:  Influence of assay procedures on the study of ouabain inhibition of (Na++K+)-ATPase in vitro.  Pharmacologist 13, 308, 1971.
• Tobin T, Baskin SI, Akera T, Brody TM:  Nucleotide specificity of the phosphorylation and [3H]-ouabain binding reactions of (Na++K+)-ATPase.  Fed Proc 31, 583, 1972.
• Akera T, Baskin SI, Tobin T:  Potassium-induced conformational transition of the ouabain (Na++K+)-ATPase complex.  Fluorescent probe studies.  Fed Proc 31, 591, 1972.
• Tobin T, Lee Cy, Akera T, Baskin SI, Brody TM:  Effects of ethacrynic acid on the duration of transient pulses of [3H]-ouabain binding to guinea pig kidney (Na++K+)-ATPase.  Proc Fifth Int’l Congress of Pharmacology, San Francisco, p 243, 1972.
• Akera T, Lee CY, Baskin SI, Tobin T, Brody TM, Takahashi T: Comparative effects of chlorpromazine and its free radical on cytoplasmic membrane phenomena.  Proc Fifth Int’l Congress on Pharmacology, San Francisco, p 3, 1972.
• Tobin T, Akera T, Baskin SI, Brody TM:  The mechanism of the calcium ion inhibition of Na ++k+-ATPase.  Proc Fifth Int’l Study Group for Research in Cardiac Metabolism, Winnipeg, p 82, 1972.
• Akera T, Baskin SI, Tobin T, Brody TM:  Cardiac glycosides: Temporal relationship between the inotropic action and binding to and dissociation from Na++K+-ATPase in vitro.  Proc Fifth Int’l Study Group for Research on Cardiac Metabolism, Winnipeg, p 80, 1972.
• Tobin T, Banerjee SP, Sen  AK:  Ligand sensitivity of [3H]-ouabain binding to native and ethacrynic acid-treated enzyme.  Irish J Med Sci, 1972.
• Baskin SI, Akera T, Tobin T, Brody SL, Puckett CR:  Effect of potassium canrenoate on cardiac functions and on Na++K+-ATPase.  Fed Proc 32, 811, 1973.
• Tobin T, Akera T, Baskin SI, Brody TM:  [3H]-ouabain binding to Na++K+-ATPase: Inhibition by,-methylene ATP.  Fed Proc 32, 709, 1973.
• Tobin T, Brody TM, Lu MC: Reversible interaction of strophanthidin-bromacetate with the cardiotonic site of (Na-K) ATPase.  Pharmacologist 15, 224, 1973.
• Akera T, Tobin T, Ting D, Shieh I-S, Gatti A, Brody TM:  Stabilizing effects of potassium on the ouabain-(Na++K+)-ATPase complex.  Pharmacologist 15, 224, 1973.
• Baskin TM, Akera T, Tobin T, Brody TM:  Effect of 7,8-dihydrochlorpromazine on Na-K-ATPase and cardiac function.  Pharmacologist 15, 224, 1973.
• Brody TM, Akera T, Tobin T, So RHM:  Mechanical shaking of Na-K-ATPase: Loss of catalytic activity and release of specifically bound cardiac glycosides.  Pharmacologist 15, 224, 1973.
• Akera T, Baskin SI, Tobin T, Brody TM, Manian AA: 7,8-Dihydrochloropromazine:  (Na++K+)-ATPase inhibition and positive inotropic effect.  Presented at Third Int’l Symposium on Phenothiazines and Related Drugs, NIMU, Rockville, MD, June 25-28, 1973.
• Tobin T, Akera T, Ku D, Brody TM, Lu MC:  Strophanthidin-bromacetate: Reversible interaction with the cardiotonic steroid binding site of Na++K+-ATPase.  Third Annual Michigan Cardiovascular Research Forum, Ann Arbor, Sept 25, 1973.
• Tobin T:  Studies on the two phosphoenzyme conformations of Na++K+-ATPase.  NY Acad Sci Meeting on NA++K+-ATPase.  NY Acad Sci, NY, Nov 1973.
• Tobin T:  Lithium ion and Na++K+-ATPase: A molecular basis for its pharmacological actions.  Winter Brain Research Conference, Steamboat Springs, CO, January 1974.
• Tobin T, Akera T, Brody TM:  Lithium, rubidium and Na ++K+-ATPase: A molecular basis for their pharmacological actions.  Fed Proc 33, 483, 1974.
• Akera T, Tobin T, Brody TM:  Ouabain-Na++K+-ATPase complex: Evidence for more than two forms.  Fed Proc 33, 491, 1974.
• Tobin T, Akera T, Taneja HR, Brody TM:  Affinity labeling of Na ++K+-ATPase. I. Strophanthidin 3,5-bisparabenzylbenzoate, a photochemical analogue of strophanthidin.  Canad Fed Biol Societies, presentation, Societies Meeting, Hamilton, Ontario, June 1974.
• Ku D, Akera T, Tobin T, Brody TM:  Effects of monovalent cations on cardiac Na, K-ATPase activity and on contractile force.  Pharmacologist 15, 326, 1974.
• Tobin T, Akera T, Ku D, Brody TM:  Cassaine: Its mechanism of inhibition of Na++K+-ATPase and the relationship of this inhibition to its cardiotonic actions.  Fourth Annual Michigan Cardiovascular Research Conference, Detroit, MI, September 20, 1974.
• Akera T, Young RC, Tobin T, Brody TM:  Estimation of maximal ouabain binding to Na, K-ATPase and tissue differences in enzyme turnover.  Pharmacologist 16, 293, 1974.
• Tobin T, Akera T, Brody TM:  Shodowmycin a nucleotide site directed inhibitor of Na ++K+-ATPase.  Fed Proc 34, 715, 1975.
• Tobin T, Abramson H:  Affinity labeling of Na ++K+-ATPase: Digoxigenin-3-12-di-bromacetate, an alkylating derivative of digoxigenin.  Presented at 1975 Winter Conference for Brain Research, Steamboat Springs, CO.
• Ku D, Akera T, Tobin T, Brody TM:  Comparative species studies on the effect of monovalent cations and ouabain on cardiac Na++K+-ATPase and contractile force.  Fed Proc 34, 792, 1975.
• Tobin T, Blake JW:  The pharmacokinetics and behavioral effects of procaine in Thoroughbred horses.  Second Int’l Doping Research and Control Conference, Newmarket, England, May 1976.
• Roberts BL, Blake JW, Tobin T:  Pharmacodynamics and drug interactions of furosemide in the horse.  1st Int’l Toxicology Conference, Toronto, Ontario, 1977.
• Miller JR, Blake JW, Tobin T:  Detection and pharmacokinetics of apomorphine in the horse.  1st Int’l Toxicology Conference, Toronto, Ontario, 1977.
• Widest SA, Akera T, Brody TM, Tobin T:  Effects of potassium on the inotropic action of digoxin.  Fed Mtgs, Chicago, 1977.
• White CG, Woods WE, Tobin T:  The pharmacology of reserpine in the horse. II. Effects of reserpine and imipramine on platelet uptake of serotonin. 7th Int’l Congress of Pharmacology, Paris, France, 1978.
• White CG, Woods WE, Tobin T:  Biochemical and behavioral effects of reserpine in the horse.  For presentation and publication, SOT Mtg, New Orleans, March 1979.
• Shults T, Combie J, Dougherty J, Tobin T:  Pharmacokinetics and behavioral effects of cocaine in the horse.  For presentation and publication, SOT Mtg, New Orleans, LA, March 1979.
• Combie J, Shults T, Nugent E, Tobin T:  Pharmacokinetics and behavioral effects of fentanyl in the horse.  For presentation and publication, SOT Mtg, New Orleans, LA, March 1979.
• Combie J, Shults, Tobin T:  The pharmacokinetics and behavioral effects of fentanyl and other narcotic analgesics in the horse.  Abstr, Third Int’l Symposium on Equine Medication Control, Lexington, KY, 1979.41.Shults T, Combie J, Dougherty J, Tobin T:  Variable interval scheduling in the horse: A sensitive measure of behavior. Ibid, 1979.
• Chay S, Woods WE, Tobin T:  The pharmacokinetics of flunixin in the horse.  Third Symposium of American Academy of Veterinary Pharmacology and Therapeutics, Ohio State University, Columbus, 1982.
• Weld JM, Combie J, Nugent T, Oeltgen P, Tobin T:  Hemorrhagic and endotoxin shock in horses: Effects of naloxone treatment on cardiovascular performance.  Ibid, 1982.
• Chay S, Woods WE, Tobin T:  The pharmacokinetics and blood levels of furosemide after intravenous administration.  Fifth Int’l Conf Control of Use of Drugs in Race Horses. Toronto, Canada, 1983.
• Houston TE, Tobin T, Blake JW:  The effect of urinary pH on oxyphenbutazone concentrations in equine urine.  Ibid, 1983.
• Collett LJ, Kamerling S, Nugent T, Weckman TJ, Woods WE, DeQuick D, Tobin T:  Clearance times and behavioral effects of clenbuterol in the horse. Ibid. 1983.
• Kamerling S, DeQuick D, Nugent T, Weckman TJ, Tobin T:  Phenylbutazone: Lack of effect on normal cutaneous pain perception in the horse.  Ibid, 1983.

(AFTER 1983 ABSTRACTS WERE NO LONGER RECORDED FOR A PERIOD, THEN RECORDING COMMENCED AGAIN FOR A PERIOD IN 1991)

• Jeganathan, A., Park, O.S., Steviov, I., Ravard, A., Vasudevan, S., Yang, J., Stanley, S., Woods, W.E., Tai, H-H., Blake, J.W., Tobin, T., and Watt, D.: Strategies for the development of effective ELISA tests for controlling medicants and illegal drugs in racing horses.  Submitted for presentation at The World Veterinary Conference XXIV, Rio De Janeiro, Brazil, Aug.  1991.
• Yang, J., Stanley, S., Jeganathan, A., Park, O.S., Steviov, I., Ravard, A., Vasudevan, S., Woods, W.E., Watt, D., Tai, H-H., Blake, J.W., and Tobin, T.: High sensitivity ELISA tests for drugs abused in racing horses. Submitted for presentation at The World Veterinary Conference XXIV, Rio De Janeiro, Brazil Aug., 1991. 
• Roth, L., Harbison, R.D., James, R.C., Tobin, T., and Roberts, S.M.:  Localization of cocaine and metabolites in liver sections: Effect of enzyme inducer pretreatment.  Submitted for publication and presentation, SOT Mtg, Seattle, WA, February 1992.
• Stanley, S.D., Huffman, M., Sadove, D., Cole, N., Diana, J.N., Tai, H-H., Gairola, C.G. and Tobin, T.  Salivary levels of cotinine and wound healing in post-surgical patients: A preliminary report.  Submitted for publication and presentation, SOT Mtg, Seattle, WA, February 1992.
• Gairola, C.G., Stanley, S.D., Diana, J.N., Tai, H-H. and Tobin, T.:  Urinary excretion of cotinine in chronically cigarette smoke-exposed mice.  Submitted for publication and presentation, SOT Mtg, Seattle, WA, February 1992.
• Yang, J.M., Woods, W.E., Tai, H-H., Watt, D.S. and Tobin, T.:  Development of highly sensitive ELISA for fluphenazine in horses.  Submitted for publication and presentation, SOT Mtg, Seattle, WA, February 1992.
• Woods, W.E., Stanley, S., Yang, J-M., Cook, D., Gerkin, D., Detra, R., Sams, R., Watt, D., Tai, H-H., and Tobin, T.: ELISA detection of azaperone the race-horse.  Submitted for presentation at The Ninth International Conference of Racing Analysts and Veterinarians.  New Orleans, LA, March,1992.
• Stanley, S.D.,  Wood, T.W., Selonen, J.S., Yang, J-M., Watt, D., Tai, H- H., and Tobin, T.: Detomidine clearance in the horse as determined by ELISA.  Submitted for presentation at The Ninth International Conference of Racing Analyst and Veterinarians.  New Orleans, LA, March, 1992.
• Yang, J-M., Stanley, S., Woods, W.E., Cook, D., Tai, H-H., Watt, D., and Tobin, T.: The procaine ELISA screening in racing horses. Submitted for presentation at The Ninth International Conference of Racing Analyst and Veterinarians.  New Orleans, LA, March, 1992.
• Roth L, Harbison R, James R, Tobin T, Roberts S.  Cocaine hepatotoxicity: Influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis.  Submitted for publication to SOT, Seattle, Washington, 1992.
• Stanley, SC, Huffman, M, Sadove, Rn, Cole, N, Diana JN, Gairola CG, Tai H-H and Tobin T:  Salivary levels of cotinine and wound healing in post-surgical patients: a preliminary report.  Society of Toxicology.  Annual Meeting, Seattle, Washington, February, 1992.
• Determination of highest no-effect doses (HNEDS) for local anesthetic responses to procaine, cocaine, bupivacaine and benzocaine in thoroughbred mares.
• Character and duration of pharmacological effects of intravenous isoxsuprine.
• Significance of procaine residues in post-race urine samples.
• Effect of a-phenyl-tert-butylnitrone on endotoxin toxemia in horses.
• The pharmacokinetics and bioavailability of amantadine in the horse:  A preliminary report.
• An analysis of prohibited substances in Kentucky with emphasis on strategies for practitioners to avoid problems.
• Quantification of the sedative effect of amitraz in the horse.
• An overview of dietary, environmental and endogenous substances of regulatory concern in racing horses.
• Fifth Symposium of Environmental Toxicology and Risk Assessment:  Biomarkers and Risk Assessment. An Overview of Dietary, Environmental and Endogenous Substances of Regulatory Concern in Racing Horses.
• Testing for Drugs, Medications and Other Substances in Racing Horses.
• Quantification of the Sedative Effect of Amitraz in the Horse.
• Character and Duration of Pharmacological Effects of Intravenous Isoxsuprine.
• Significance of Procaine Residues in Post-Race Urine Samples.
• Effect of a-Phenyl-tert-butylnitrone on Endotoxin Toxemia in Horses.
• Determination of Highest No-Effect Doses (HNEDS) for Local Anesthetic Responses to    
• Procaine, Cocaine, Bupivacaine, and Benzocaine in Thoroughbred Mares.
• Quantitation of the Locomotor Effect of Therapeutic Medication in a Behavior Chamber.
• ELISA and GC/MS Detection of Cocaine.
• Testing for Therapeutic medications, Environmental and Dietary Substances in Racing Horses:  Outcomes of the Workshop Held in Lexington, August, 1994.
• A Review of a Consequence of Highly Sensitive Drug Testing: The Need for Data on Analytical/ Pharmacological Relationships for Therapeutic Medications.
• Lidocaine: Dose Response Relationships and Analytical Detection in Horses.
• Pharmacokinetics and Bioavailability of Amantadine in the Horse: A Preliminary Report.
• Analytical Detection and Preliminary Pharmacokinetics of Toltrazuril and Diclazuril in the Horse.
• A Clinical Report of Diclazuril Treatment for Equine Protozoal Myeloencephalitis.
• Diclazuril and Equine Protozoal Myeloencephalitis.
• Development of an Equine Behavior Chamber and Effects of Amitraz, Detomidine, and Acepromazine on Spontaneous Locomotor Activity.
• Preliminary Pharmacokinetics of Diclazuril and Toltrazuril in the Horse.
• Therapeutic Efficacy of Rimantadine HCL in Experimentally Induced Influenza:  An Illness in Horses.
• Review of a Consequence of Highly Sensitive Drug Testing: The Need for Data on Analytical-Pharmacological Relationships for Therapeutic Medications.
• Testing for Therapeutic Medications: Analytical / Pharmacological Relationships and the Need for Limitations on the Sensitivity of Testing for Certain Agents- A Work in Progress.  Jan. 22, 1998.
• Detection and Quantitation of 2-Hydroxylidocaine in Horse Urine.
• ELISA Assay for Fluoxetine.
• Detection and Quantitation of 3-Hydroxybupivacaine in Horse Urine.
• Detection and Quantitation of 3-Hydroxymepivacaine in Horse Urine.
• Karpiesiuk W, Lehner AF, Fisher M, Tobin T: Synthesis of the Equine Metabolites of Four Xylidide Local Anesthetics.  65th Annual Meeting AORC, March, 1999.
• Harkins JD, Holtz C, Boyles J, Woods E, Lehner AF, Carter W, Karpiesiuk W, Fisher M, Tobin T: Behavioral and Cardiac Effects of Clenbuterol and Furosemide in the Horse: An Overview.  65th Annual Meeting AORC, March, 1999.
• Dirikolu L, Lehner F, Harkins JD, Woods WE, Carter WG, Karpiesiuk W, Boyles J, Fisher M, Tobin T: Identification of Lidocaine and Its Metabolites in Post Administration Equine Urine By Elisa and MS/MS.  65th Annual Meeting AORC, March, 1999.
• Woods WE, Lehner A, Bosken J, Holtz C, Fisher M, Tobin T: Elisa and GC/MS Detection of Isoxsuprine in Equine Urine.  65th Annual Meeting AORC, March, 1999.
• Carter WG, Lehner AF, Dirikolu L, Woods WE, Karpiesiuk W, Harkins JD, Boyles JE, Jacobs J, Fisher M, Tobin T: Detection and Characterization of Ropivacaine Metabolites in Horse Urine.  65th Annual Meeting AORC, March, 1999.
• Holtz C, Woods WE, Dirikolu L, Lehner F, Carter W, Harkins JD, Karpiesiuk W, Fisher M, Tobin T: Clenbuterol in the Horse: A Preliminary Analytical Report.  65th Annual Meeting AORC, March, 1999.
• Lehner AF, Hunsucker A, Bosken JM, Harkins JD, Woods WE, Karpiesiuk W, Carter WG, Boyles J, Fisher M, Tobin T: Further Characterization of Equine Isoxsuprine Metabolites By Electrospray Ionization Tandem Mass Spectrometry.  65th Annual Meeting AORC, March, 1999.
• Bosken JM, Lehner AF, Hunsucker A, Harkins JD, Woods WE, Karpiesiuk W, Carter WG, Boyles J, Fisher M, Tobin T: Isoxsuprine Conjugates Identified in Equine Urine By Direct Injection ESI/MS/MS. 65th Annual Meeting AORC, March 1999.
• Boyles J, Woods WE, Harkins D, Lehner F, Karpiesiuk W, Dirikolu L, Bosken J, Carter W, Jacobs J, Fisher M, Tobin T: Procedures and Quality Assurance Aspects of the Testing Integrity Program. 65th Annual Meeting AORC, March 1999.
• Harkins, JD and Tobin T. Highest No-Effect Dose for Pharmacological Responses to Acepromazine in the Horse: A Preliminary Communication. Research Committee of the Testing Integrity Program, May 2002.
• Tobin T, McDowell K, Hughes C, Lehner A, Crutchfield J, Harkins JD, Dirikolu L, Sebastian M, Harrison L, Williams N, Smith R, Webb B, Bush L, Newman K, Allman R, Dwyer R and Powell D: The Kentucky 2001 Mare Reproductive Loss Syndrome: Overview and Preliminary Toxicological Approaches. 14th International Conference of Racing Analysts and Veterinarians, July 2002.
• Dirikolu L, Lehner AF, Hughes C, Karpiesiuk W, Camargo FC, Harkins JD, Woods WE, Bosken J, Boyles J, Troppmann A, Fisher M and Tobin T: Detection, Quantification and Pharmacokinetics of Furosemide (Salixâ) Following Intravenous Administrations in Horses. 14th International Conference of Racing Analysts and Veterinarians, July 2002.
• Harkins JD and Tobin T: Pharmacodynamics of Guanabenz and Related a Agonists. 14th International Conference of Racing Analysts and Veterinarians, July 2002.
• Lehner A.F, Hughes C, Woods WE, Harkins JD, Karpiesiuk W, Dirikolu L, Bosken J, Boyles J, Troppmann A, Fisher M and Tobin T: Proposed Methodology for the Detection of Oxyglobinâ in Equine Plasma. 14th International Conference of Racing Analysts and Veterinarians, July 2002.
• Karpiesiuk W, Lehner AF, Dirikolu L, Fisher M, Tobin T: Synthesis and Characterization of Deuterated Standard of Furosemide (Salixâ). 14th International Conference of Racing Analysts and Veterinarians, July 2002.
• Hughes C, Lehner A, Crutchfield J, Woods W, Harkins J, Karpiesiuk W, Dirikolu L, Sebastian M, Troppmann A, Boyles J, Bosken J, Harrison L, Tobin T: Analytical Detection and “Normal” Population Data of Cyanide and Thiocyanate in Equine Blood and Serum. 14th International Conference of Racing Analysts and Veterinarians, July 2002.
• Camargo F, Dirikolu L, Sebastian M, Hughes C, Crutchfield J, Harkins D, Boyles J, Troppmann A, McDowell K, Harrison L and Tobin T: The Toxicokinetics of Cyanide and Mandelonitrile in the Horse and Their Relevance to the Mare Reproductive Loss Syndrome. 14th International Conference of Racing Analysts and Veterinarians, July 2002.
• Dirikolu L, Mollett BA, Woods WE, Bratton C, Lehner AF, Karpiesiuk W, Hughes C, Boyles J, Harkins JD, Troppmann A, and Tobin T: ELISA “Detection Times” of Albuterol after Torpexä Administration: A Preliminary Report. 14th International Conference of Racing Analysts and Veterinarians, July 2002.
• Certified Reference Standards and Stable Isotope Internal Standards for Equine Medication Regulation. Seventh Kentucky Innovation and Entrepreneurship Conference (KSEF). Louisville, KY. May 2011.
• Equine Medication Regulation: Stable Isotope Internal Standards and Certified Reference Standards. Sixth Kentucky Innovation and Entrepreneurship Conference (KSEF). Lexington, KY. April 2010.
• R. Eisenberg, S. Kudrimoti, C. G. Hughes, G. A. Maylin, and T. Tobin. Dihydromethylprednisone, an isomeric metabolite of methylprednisolone: synthesis of an analytical standard. Presented at the 20th International Conference of Racing Analysts and Veterinarians, Sugar Beach, Mauritius, September 2014.
• Fenger, Clara K., Tobin, Thomas, Casey, Patrick J., Roualdes, Edward A., Langemeier, John L., and Haines, Deborah M.  Effects of Bovine Colostrum on Performance and Recovery in Racing Thoroughbreds: Abstract and Presented at the 20th International Conference of Racing Analysts and Veterinarians, Sugar Beach, Port St. Louis, Mauritius, September 15th, 2014.
• C. Richard Harden, Kimberly Brewer, Charlie Hughes, and Thomas Tobin. "Shipping-in" – a risk factor associated with fatal musculoskeletal racing injuries Abstract and Presented at the 20th International Conference of Racing Analysts and Veterinarians, Sugar Beach, Port St. Louis, Mauritius, September 15th, 2014
• S. Kudrimoti, R. Eisenberg, G. A. Maylin, Charlie Hughes, and T. Tobin.  Synthesis and characterization of 4-hydroxyxylazine and 4-hydroxyxylazine-d6 standards for use in xylazine regulation in competition horses:  Presented at the 20th International Conference of Racing Analysts and Veterinarians, Sugar Beach, Port St. Louis, Mauritius, September 15th 2014
• S. Kudrimoti, R. Eisenberg, G. A. Maylin, C.G. Hughes and T. Tobin. 20-Dihydroprednisone: Synthesis of an isomeric equine metabolite of prednisolone for use as an analytical standard;  Presented at the 20th International Conference of Racing Analysts and Veterinarians, Sugar Beach, Port St. Louis, Mauritius, September 15th 2014
• A.M. Briceño, A.M. Sanchez, R.H. Galley, K. Brewer, C. Hughes, T. Tobin. Increased Incidence of Sudden Death Associated with Exercise Induced Pulmonary Hemorrhage (EIPH) in Horses Racing at Higher Altitude in Venezuela:  Presented at the 20th International Conference of Racing Analysts and Veterinarians, Sugar Beach, Port St. Louis, Mauritius, September 15th  2014
• A. Morales, A. Méndez, M. Armas, C. Guarino, M. Moya, E. Suniaga, K. Brewer, T. Tobin. 2.2 Título del Trabajo: Efecto de la terapéutica combinada Levotiroxina-Clembuterol en ratones Balb/c y ratas Sprague-Dawley. 2.3 Nombre del Congreso (entidad patrocinante): 76 Aniversario del Instituto Nacional de Higiene Rafael Rangel y 37 Jornadas Científicas 2.4 Fecha: Noviembre, 2014. 2.5 Ciudad y País: Caracas, Venezuela
• A. Morales, A. Méndez, M. Armas, C. Guarino, M. Moya, E. Suniaga, K. Brewer, T. Tobin. 3.2 Título del Trabajo: Efecto de la terapéutica combinada Levotiroxina-Clembuterol sobre la arteria aorta en ratones Balb/c. 3.3 Nombre del Congreso (entidad patrocinante): 76 Aniversario del Instituto Nacional de Higiene Rafael Rangel y 37 Jornadas Científicas 3.4 Fecha: Noviembre, 2014. 3.5 Ciudad y País: Caracas, Venezuela
• A. Morales, A. Mendez, M. Armas, C. Guarino, M. Moya, E. Suniaga, K. Brewer, T. Tobin. 4.2 Título del Trabajo: Efecto de la levotiroxina-clembuterol sobre la arteria aorta en ratas Sprague Dawley. 4.3 Nombre del Congreso (entidad patrocinante): XXIII Jornadas Científicas Dr. Francisco de Venanzi, Instituto de Medicina Experimental Dr. José Gregorio Hernández. 4.4 Fecha: Noviembre, 2014. 4.5 Ciudad y País: Caracas, Venezuela

Cumulative research and other support, 1970 – October 1, 2017: About $US16,000,000.00
Tobin, Thomas, May 18th, 1983 Testimony in Hearings before the Subcommittee on Criminal Justice of the Committee on the Judiciary, House of Representatives 98th Congress, First Session on Corrupt Horseracing Practices, May 18, 1983 serial number 156, starting page 116 and including analysis and rebuttal of previous testimony, testimony by T Tobin, responses to questions by committee members and extensive supporting documentation including many Tobin publications.